


















































































accessing	 chiral	 secondary	 amines.	 These	 are	 important	 building	 blocks	 in	 the	
production	of	many	high-added	 value	 chemicals,	with	 an	 estimated	 40-45	%	of	 all	
pharmaceuticals	and	20	%	of	agrochemicals	containing	a	chiral	amine	intermediate.	
However,	most	of	their	current	methods	of	manufacture	are	inefficient	and	wasteful.	














hydrophobic	binding	pocket.	Both	 imines	 and	amines	were	 shown	 to	act	 as	mixed	
inhibitors	of	the	native	TADH	activity,	and	it	was	suggested	that	inhibition	occurred	
due	 to	 binding	 elsewhere	 in	 the	 active	 site.	 Three	 approaches	 were	 investigated	
towards	the	engineering	the	TADH	active	site	to	avoid	inhibition	and	promote	imine	
activation,	based	on	both	genetic	and	chemical	modifications.		




















































































































































































































Chiral	 amines	 are	 important	 constituents	 of	 many	 bioactive	 compounds,	 such	 as	
natural	products,	pharmaceuticals	and	agrochemicals.	They	also	have	notable	use	as	
ligands	in	transition	metal	catalysis	or	as	chiral	organocatalysts,	as	well	as	resolving	
agents	 for	 the	separation	of	enantiomers	via	diastereomeric	 salt	 formation.1	 It	has	
been	 estimated	 that	 approximately	 40-45	 %	 of	 pharmaceuticals	 and	 20	 %	 of	






































































synthesis	of	chiral	amines.7	A	particularly	efficient	route	 is	 the	reduction	of	 imines,	
which	 in	 turn	can	be	prepared	 from	the	corresponding	ketones	 (Figure	1.2).	When	
imine	formation	and	reduction	occur	sequentially	in	one	pot,	the	reaction	is	referred	






primary	 amine	 reacting	with	 the	 carbonyl	 group	 of	 the	 ketone.	 However,	 when	 a	






















































Traditional	 methods	 for	 secondary	 amine	 synthesis	 via	 this	 route	 are	 energy-
consuming,	 not	 very	 efficient	 and	 generate	 waste.	 As	 a	 consequence,	 there	 is	 an	
interest	to	develop	better	routes	for	the	reduction	of	carbon-nitrogen	double	bonds	





been	 slow,	 compared	 to	 the	 numerous	 reduction	 methods	 of	 their	 carbonyl	
counterparts.	 Nonetheless,	 important	 advances	 were	 made	 in	 the	 early	 2000’s	




Early	 efforts	 to	 asymmetrically	 reduce	 imines	 focused	 on	 the	 development	 of	




accessed	 from	 either	molecular	 hydrogen	 (a	 reaction	 known	 as	 hydrogenation)	 or	
from	 an	 organic	 hydrogen	 source	 (Figure	 1.4),	 such	 as	 2-propanol,	 formic	 acid	 or	



























al.	 reported	 the	 asymmetric	 hydrogenation	of	N-benzyl	 imines	 in	 a	 biphasic	water	







based	 complex	 Ir-xyliphos	 is	 employed	 in	 the	 industrial	 process	 for	 the	
11	
	
enantioselective	 reduction	of	 the	 imine	precursor	of	 the	herbicide	 (S)-Metolachlor,	
commercially	known	as	Dual	Mangum®	(Figure	1.7).13		
	




imines	 with	 high	 enantioselectivities	 (77-97	 %	 ee).	 The	 same	 authors	 had	 initially	
developed	 these	 complexes	 for	 the	 transfer	 hydrogenation	 of	 ketones.	 The	 piano-


















80 bar H2, 50 oC
Xyliphos:




















5:2 HCOOH / Et3N, Solvent
28 oC, 0.5-1 % mol catalyst, 3-36 h
72-97 % yield




ligand.	 Instead	 of	 hydrogen,	 the	 formic	 acid-triethylamine	 mixture	 was	 used	 as	
hydride	source	(Figure	1.8).14	









Figure	 1.9.	 General	 structures	 of	 half-sandwich	 Ru(II),	 Rh(III)	 and	 Ir(III)	 p-complexes	 for	 the	
asymmetric	transfer	hydrogenation	of	ketones	and	imines.	
The	most	 common	 hydride	 sources	 are	 the	 azeotropic	mixture	 of	 formic	 acid	 and	
triethylamine	(HCOOH	/	Et3N)15	and	alcohols	such	as	isopropanol	(iPrOH).16	Aqueous	








have	 been	 reported	 to	 promote	 reduction	 of	 imines.	 Efficient	 catalysts	 include	


































The	general	mechanism	 for	 the	metal-catalysed	 reduction	of	 carbonyls	 and	 imines	
involves	 formation	 of	 the	 metal	 hydride,	 followed	 by	 its	 transfer	 to	 the	
substrate.18,26,27	The	mechanisms	of	ketone	and	imine	reduction	are	very	similar	and	
metal	complexes	used	for	this	catalysis	are	generally	quite	similar	too.	The	full	catalytic	















characterised	as	outer	 sphere.28	 In	both	pathways	 the	metal	hydride	 is	 transferred	
onto	the	sp2-carbon,	which	is	activated	differently	depending	on	the	mechanism.		
In	 the	 inner	 sphere	mechanism,	 the	metal	 centre	 acts	 as	 a	 Lewis	 acid,	with	 imine	
activation	occurring	by	coordination	to	the	metal	centre	via	a	vacant	coordination	site,	
followed	by	protonation	of	the	heteroatom	by	the	protic	solvent.	In	the	outer	sphere	
mechanism,	 the	 hydride	 and	 proton	 are	 transferred	 in	 a	 concerted	 polarised	 or	






































































to	yield	an	 iminium	 ion,	which	 is	 then	reduced	to	the	corresponding	amine	 (Figure	
1.13).31	Others	have	also	confirmed	this	ionic	mechanism.32,33	Norton	clearly	defined	










































































Several	 examples	 of	 aqueous-phase	 transfer	 hydrogenation	 reactions	 have	 been	
reported.17,36-39	Generally,	water-soluble	catalysts	contain	 ligands	with	sulfonic	acid	
functionalities	 and	 sodium	 formate	 is	 employed	 as	 the	 hydrogen	 source.	 The	 low	
solubility	of	the	substrates	in	the	reaction	mixture	does	not	seem	to	affect	the	yields.36	
The	 pH	 has	 a	 critical	 influence	 on	 rate	 and	 enantioselectivity	 as	 highlighted	 in	
investigations	 by	 both	 Ogo	 et.	 al.40	 and	 Wu	 et.	 al.41	 In	 contrast	 to	 ketones,	 an	
important	issue	for	aqueous	imine	reduction	is	the	hydrolysis	of	imines	in	water,	to	
form	 the	 corresponding	 carbonyl	 and	 amine	 precursors.	 The	 use	 of	 cyclic	 imines	
minimises	 this	problem.42	Some	acyclic	 imines	derived	 from	aryl	ketones	have	also	
been	successfully	used	in	aqueous	systems.	
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A	 biologically	 inspired	 approach	 to	 imine	 reduction	 was	 recently	 reported,	 which	
utilises	a	rhodium	complex	tethered	to	Hantszch	ester.	Hantszch	esters	are	commonly	
used	 in	 transfer	 hydrogenation	 as	 mimics	 of	 the	 biological	 NAD(P)H	 cofactor.43-46			
Colbran	and	co-workers	developed	this	bio-inspired	metal	complex	as	an	active	site	
mimic	of	alcohol	dehydrogenase	for	imine	reduction.47	The	basic	mechanism	involved	
imine	 activation	by	 direct	 coordination	 to	 the	metal	 centre	 acting	 as	 a	 Lewis	 acid,	
hydride	 transfer	 from	 the	 tethered	 dihydropyridine	 ligand,	 followed	 by	 proton	





















discovery	 and	 development	 of	 biocatalysts	 capable	 of	 enantioselective	 imine	
reduction,	 as	 a	 direct	 approach	 to	 chiral	 amines.	 Until	 recently,	 this	 reaction	 was	
assumed	to	be	absent	from	nature’s	enzymatic	toolbox.	Currently,	various	enzymatic	
routes	exist	 for	 the	synthesis	of	optically	active	primary	amines,	 such	as	 (dynamic)	
kinetic	 resolution	 using	 hydrolases,	 asymmetric	 synthesis	 using	 amine	






efforts	 into	 the	 search	 and	 development	 of	 biocatalysts	 for	 asymmetric	 imine	
reduction	 have	 been	 emerging.	 At	 the	 beginning	 of	 this	 thesis,	 the	 number	 of	
published	examples	of	enzymes	exhibiting	 imine	reductase52	activity	was	 limited	to	
Candida	 parapsilosis	 (ATCC	 7330),53	 Pseudomonas54-56	 and	 Streptomyces	 sp;52,57,58	
strains	 reported	 to	possess	 this	activity.	 Since	 these	 initial	 reports,	much	work	has	
gone	 into	the	discovery	and	development	of	 imine	reductases	and	the	number	has	





as	 a	 biocatalyst	 for	 the	 asymmetric	 reduction	 of	 α-	 and	 β-	 keto	 esters59-60	 was	
investigated	for	asymmetric	 imine	reduction,	due	to	the	chemical	analogy	between	








Li	 et	 al.	 demonstrated	 the	 use	 of	 a	 dynamic	 combinatorial	 screen	 as	 a	 versatile	
approach	 for	 the	 discovery	 of	 imine	 reductase	 activity.61	 They	 used	whole	 cells	 of	
Acetobacterium	woodii,	an	anaerobic	bacterium	which	reduces	C=C	double	bonds	as	
part	 of	 a	 respiratory	 process,	 to	 reduce	 aldimines,	 formed	 in	 situ	 from	 the	
corresponding	amines	and	aldehydes.	The	products	were	obtained	in	low	quantities,	
and	the	enzymes	responsible	for	this	reaction	were	not	identified.	
Enzymes	 from	 Pseudomonas	 putida	 ATCC	 1263355	 and	 Pseudomonas	 syringe	 pv.	
tomato56	 were	 also	 observed	 to	 possess	 imine	 reductase	 activity	 towards																										
Δ1-piperidine-2-carboxylate	 and	 Δ1-pyrroline-2-carboxylate,	 producing	 the	
corresponding	 (S)-amines	 in	 the	 presence	 of	 NADPH	 as	 the	 cofactor	 (Figure	 1.16).	









water, 25 oC, 3 hr
(R)
55 - 80 % yield























same	 research	 group	 purified	 and	 characterised	 the	 corresponding	 enzymes	





























only	 active	with	 2-methyl-1-pyrroline,67	whereas	 the	 (S)-imine	 reductase	 ((S)-IRED)	
Streptomyces	sp.	GF3546	displayed	a	broader	substrate	specificity	(Figure	1.19a).52		
Turner	and	collaborators	extended	this	investigation	into	(S)-IRED	from	Streptomyces	





catalyse	 the	 reduction	 of	 a	 range	 of	 substituted	 dihydroisoquinolines	 and	 1-
substituted	dihydro-β-carbolines	with	excellent	ee	values	(>98	%,	Figure	1.19b).68		
Another	 example	 of	 a	 tailor-made	whole	 cell	 catalyst	was	 designed	more	 recently	
using	 imine	 reductase	 from	 Streptomyces	 viridochromogenes,	 alongside	 glucose	
dehydrogenase	from	Bacillus	subtilis,	for	in	situ	cofactor	regeneration.	The	system	was	
incorporated	and	expressed	in	E.coli,	and	was	shown	to	effectively	reduce	the	model	
substrate	 1-methyl-3,4-dihydroisoquinoline	 at	 high	 substrate	 concentrations	 (100	
mM)	with	 high	 conversion	 and	 excellent	 enantioselectivity	 (>99	%	 ee).	 This	was	 a	
promising	 result	 towards	 any	 future	 whole-cell	 enantioselective	 imine	 reduction	
processes.	
Grogan	 and	 co-workers	 reported	 a	 protein	 homologous	 to	 the	 Streptomyces	 sp.	
GF3587	(R)-IRED,	named	Q1EQE0	from	Streptomyces	kanamyceticus.58	This	enzyme	
showed	(R)-selective	imine	reduction	activity	towards	the	monocyclic	imine,	2-methyl-
1-pyrroline	 as	 well	 as	 towards	 some	 dihydroisoquinoline	 derivatives	 such	 as	 3,4-
dihydroisoquinoline,	including	an	iminium	ion	(Figure	1.19c).58	This	was	also	the	first	
structurally	characterised	IRED.	
Following	 from	 the	 successful	 isolation	 and	 application	of	 IRED	 from	Streptomyces	









examples	 of	 IREDs	 from	 different	 organisms,	 identified	 by	 screening	 of	 the	 IRED	
database,	are	briefly	discussed	next.	
The	 substrate	 spectrum	 was	 expanded	 with	 the	 discovery	 of	 the	 (S)-IRED	 from	
Amycolatopsis	 orientalis	 (AoIRED),	 which	 could	 reduce	 5-,	 6-	 and	 7-membered	




activity	 of	 0.24	 U	 /	 mg	 with	 3,4-dihydroisoquinoline,	 whereas	 SrIRED	 displayed	 a	
specific	activity	of	2.58	U	/	mg	with	2-methyl-1-pyrroline	(Figure	1.20b).	These	results	










b) Imine reduction performed using (S)-IRED Streptomyces sp. GF3546 in whole cells
N CH3 N N
+
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were	 reduced	 with	 moderate	 to	 excellent	 enantioselectivities	 (up	 to	 99	 %	 ee),	
depending	on	the	a-carbon	substituent	(Figure	1.20c).71	
1.1.3.3 Characterisation	and	mechanism	of	IREDs		






NADPH	bound	 to	 each	 subunit.	 Their	 natural	 function	 is	 unknown,	 and	 their	 large	





hydrophobic	 substrate-binding	 cleft.72	 The	 conservation	 analysis	 also	 revealed	 two	
clusters,	depending	on	the	catalytic	protic	residues.	Generally,	(R)-IREDs	are	observed	
in	 the	 larger	 cluster,	 possessing	 a	 conserved	 aspartate,	while	 known	 (S)-IREDs	 are	








Figure	 1.20.	 Substrate	 scope	 of	 asymmetric	 imine	 reduction	 with	 different	 IREDs	 identified	 by	
screening	of	the	IRED	database.	a)	AoIRED	b)	PeIRED	and	SrIRED	c)	SnIRED	highlighting	activities	and	
enantioselectivities.		
The	 IRED	mechanism	and	the	type	and	role	of	 the	catalytic	 residues	are	still	under	
debate.	The	basis	of	the	mechanism74	involves	the	enzymes	ability	to	bind	both	the	
cofactor	 and	 substrate	 in	 a	 suitable	 coordination	 for	 hydride	 transfer,	 and	 the	















R1 =  CH3 or C7H7, 
R2 = H or F
R = H or CH3
R1 =  CH3 or C6H11, R2 = H or OCH3












R = CH3, C2H5, n-C3H7, 
i-C3H7, C6H11, C6H5
SnIRED
up to 81 % yield




S.A. = 0.24 U / mg












that	 were	 structurally	 similar	 to	 this	 IRED	 were	 identified	 from	 the	 analysis:		
dihydrofolate	reductase	(DHFR)	and	Irp3	from	Yersinia	enterocolitica, both	exhibiting	
imine	 reduction	 activity	 towards	 their	 natural	 substrates,	 and	 hydroxyisobutyrate	





to	 protonation	 seems	 unlikely	 due	 to	 the	 high	 basicity	 of	 the	 resulting	 amide	
intermediate.	In	HiBDH,	Lys165	in	the	active	sites	provides	the	proton	to	the	nascent	
hydroxyl	 group.	 Superimposition	 of	 the	 Q1EQE0	 structure	 with	 HiBDH	 identified	
Asp187	at	the	place	of	the	lysine.	Genetic	modification	of	this	residue	to	asparagine	
and	alanine	resulted	 in	a	 loss	of	activity.	From	this,	the	suggested	IRED	mechanism	
involved	 imine	 protonation	 by	 Asp187,	 whose	 pKa	 is	 most	 likely	 lowered	 by	 the	
hydrophobic	residues	Leu191	and	Leu137.	The	resulting	iminium	ion	is	stabilised	by	







Figure	1.21.	a)	Suggested	mechanism	of	Q1EQE0	 IRED.	Modified	 from	Schrittwieser	et	al.	 (2015);77								
b)	Active	site	of	Q1EQE0,	with	the	suggested	catalytic	residue	Asp187	highlighted	as	yellow	sticks.	
The	 AoIRED	 structure	 co-crystallised	 with	 NADPH	 and	 the	 corresponding	 amine	









Lenz	 et	 al.	 also	 showed	 PeIRED	 and	 SrIRED	 activity	 towards	 the	 reduction	 of	 the	
carbonyl	bond	in	2,2,2-trifluoroacetophenone.74 This	demonstrated	for	the	first	time	
IRED	 reaction	 promiscuity	 towards	 the	 reduction	 of	 carbonyls	 and	 raised	 an	
interesting	question:	can	this	expansion	of	activity	be	mimicked	in	carbonyl	reductases	














bacteria.	 In	 the	mammalian	 organisms,	 they	 facilitate	 the	 breakdown	 of	 alcohols,	
which	are	toxic	to	the	body	if	left	untreated.		Whereas	in	plants,	yeast	and	bacteria,	
the	 reverse	 reaction	 occurs,	 producing	 the	 alcohol,	 as	 part	 of	 the	 fermentation	




























yeast.82	MDRs	 consist	 of	 a	 chain	 of	 approximately	 350	 amino	 acids	 per	monomer,	




depending	 on	 the	 enzyme	 and	 its	 sequence.	 In	 most	 cases	 the	 catalytic	 domain	
contains	 two	 zinc	 ions,	 one	 which	 is	 responsible	 for	 the	 catalysis	 and	 one	 that	 is	












throughout	 the	 entire	 alcohol	 dehydrogenase	 family.82	 For	 example,	 the	 spacing	











is	Drosophila	ADH	 coming	 from	 an	 insect	 species.	 The	 chain	 length	 of	 SDRs	 varies	
between	250	and	300	amino	acids,	and,	like	MDRs,	they	also	have	a	cofactor-binding	








HLADH	was	generally	used	as	 the	model	 for	 the	enzymatic	mechanism,	which	was	
suggested	based	on	crystallography,	kinetic	and	spectroscopic	 studies.	The	hydride	









the	nicotinamide	 ring	moves	deeper	 into	 the	 active	 site	 and	 the	 substrate	binding	
pocket	is	formed	(Figure	1.25).	Substrate	binding	occurs	by	coordination	of	the	oxygen	
to	the	catalytic	zinc	acting	as	a	Lewis	acid,	and	displacement	of	a	water	molecule.	In	








in	 yellow,	 representing	 the	 substrate.	 The	 metal	 binding	 residues	 are	 highlighted	 in	 red	 and	 the	




ring,	 consequently	 forming	 the	 corresponding	 carbonyl	 and	NADH.	 The	 carbonyl	 is	
released,	followed	by	release	of	NADH.	NADH	binding	to	the	enzyme	is	stronger	than	
NAD+	binding,	and	the	NADH	release	 is	classed	as	 the	rate	determining	step	 in	 the	
alcohol	oxidation.90	In	the	reverse	reaction	of	carbonyl	reduction,	coordination	of	the	












of	 the	 ternary	 complex	 TbADH-NADP+-DMSO	 (as	 ketone	 mimic),	 the	 zinc	 ion	 was	
suggested	to	be	pentacoordinated	during	hydride	transfer,	with	the	water	molecule	
acting	as	the	fifth	ligand,	instead	of	being	displaced	by	the	substrate.93	The	absence	of	
a	 proton	 relay	 system	 was	 also	 suggested	 in	 the	 TbADH	 mechanism,	 and	 was	
supported	by	the	lack	of	hydrogen	bonds	between	Ser37	and	His42	(corresponding	to	





































































































delivering	 the	 (R)-alcohol	 (following	 the	 anti-Prelog’s	 rule).	 In	 addition	 to	 the	
stereospecific	approach	of	the	substrate,	the	hydride	transfer	to	/	from	NAD(P)H	is	
also	 stereospecific:	 some	dehydrogenases	 specifically	 transfer	 the	pro-R	 hydrogen,	
while	other	transfer	the	pro-S	hydrogen	at	position	4	of	the	NAD(P)H	nicotinamide	
































a	 broad	 substrate	 range,	 including	 aldehydes,	 acyclic,	 bicyclic,	 aromatic	 and	
unsaturated	ketones,	as	well	as	diketones	and	oxo-esters	(Figure	1.28).96		
	
Figure	1.28.	 Illustration	of	 the	 substrate	 range	of	a	 range	of	 common	ADHs.	Modified	 from	Faber	
(2011).96		
Horse	liver	ADH	reduces	a	wide	range	of	substrates	with	good	to	excellent	enantio-	
and	 regio-selectivities,	 including	 cyclic	 and	 bicyclic	 ketones	 of	 medium	 size	 (4-9	
membered),	 diketones	 and	 organometallic	 compounds97,98	 (Figure	 1.29a-b).	
Molecules	 larger	 than	 decalines	 (>10	 membered	 bicyclic	 rings)	 are	 not	 as	 readily	
accepted	as	 substrates.99	While	O-	 and	S-	 containing	heterocyclic	 ketones	 are	well	
tolerated	by	HLADH,	the	presence	of	amines	(for	example	in	N-heterocyclic	ketones)	












ketones	 with	 both	 substituents	 larger	 than	 an	 ethyl	 group	 are	 not	 accepted	 as	
34	
	





















































a) Desymmetrisation of prochiral diketones
b) Enantioselective reduction of chiral organometallic moieties (eg. 1-formyl-2-
methyl(benzene)tricarbonylchromium)








many	 industrial	 processes.	 Whilst	 mesophilic	 ADHs	 such	 as	 HLADH	 have	 found	
application	 in	 biotransformations,	 these	 enzymes	 have	 been	 shown	 to	 undergo	
conformational	changes	affecting	their	activity	under	thermal	stress.107	On	the	other	
hand,	the	substrate	scope	of	TbADH	is	limited	compared	to,	for	example,	HLADH.	A	
zinc-dependent	 thermostable	 enzyme	 from	 Thermus	 sp.	 ATN1	 raised	 considerable	
interest,	due	to	its	 large	substrate	scope,	thermal	and	organic	solvent	tolerance,	as	




shown	 to	be	highly	 thermostable	 (up	 to	90	 oC).108	 The	enzyme	was	expressed	and	
purified	 from	 E.	 coli	 and	 displayed	 a	 broad	 substrate	 range,	 including	 alcohols	
(primary,	 secondary	 and	 cyclic),	 aldehydes	 and	 ketones	 (acyclic	 and	 cyclic),	with	 a	
preference	 for	 primary	 alcohols	 and	 their	 corresponding	 aldehydes.	 Excellent	
activities	 towards	 cyclohexanone	 and	 its	 derivatives	 (Figure	 1.31)	 have	 also	 been	











R1= CH3; R2= CH(CH3)2, C2H5, 
cyclo-C3H5
[R1= CF3; R2= Ph]a
[R1= Cl-CH2-; R2= CH2-CO2Et]a
R1= CH3; R2= n-C3H7, C=CH, 
CH2-CH(CH3)2, (CH2)3-Cl,        
n-C5H11, (CH2)5-Cl
R1= C2H5; R2= n-C3H7,           
(CH2)2-CO2Me, (CH2)5-Cl
R1= n-C3H7; R2= n-C3H7








TADH	was	 also	 shown	 to	 exhibit	 tolerance	 towards	water-miscible	 and	 immiscible	
organic	solvents.	Octane	and	hexane	(50	%	v	/	v)	were	shown	to	act	as	substrate	/	
product	sinks	in	two	phase	systems,	while	acetone	could	be	used	both	as	sacrificial	


















142 % 57 %
133% 100 % 47 %





















100 % 46 % 163 %
25 % 22 % 28 %
154 % 359%
b) Reductive substrate scope:
37	
	
Hollmann	 and	 co-workers	 studied	 the	 interaction	 between	 TADH	 and	 the	




The	crystal	 structure	of	TADH	was	 recently	 solved	 (PDB	 ID	4CPD),	and	 showed	 the	
occurrence	of	the	catalytic	and	structural	zinc-binding	sites.	Similar	to	other	bacterial	





C	 with	 D.	 There	 are	 numerous	 interactions	 between	 subunits,	 along	 with	 a	 high	
number	of	prolines	and	condensed	surface	loops	in	its	structure,	which	are	all	features	




have	 been	 developed.112-114	 In	 a	 different	 approach,	 mimics	 of	 the	 nicotinamide	
cofactors	 have	 been	 synthesised,	 and	 their	 use	 was	 demonstrated	 with	 certain	
NAD(P)H-dependent	reductases.		













in	production	of	 the	desired	 chiral	 alcohol,	was	 similar	even	 in	 the	absence	of	 the	
adenosine,	pyrophosphate	or	ribose	functions	of	NADH.	Any	doubts	that	activity	was	
due	 to	 residual	 binding	 and	 recycling	 of	 NADH	were	 dismissed	 in	 a	 recent	 report,	
displaying	thoroughly	performed	controls,116	showing	that	only	racemic	alcohol	was	
detected	in	the	absence	of	reduced	analogues	9r	and	10r.	
Hollmann	 and	 co-workers	 also	 used	 compound	 9r	 and	 its	 derivatives	 as	 synthetic	








were	 examined.	 These	 metals	 include	 Co(II),117	 Ni(II),118	 Cu(I)	 and	 (II),119	 Fe(II),120	
Mn,121	as	well	as	a	second	row	transition	metal,	Cd(II).	Bogin	et	al.	reported	the	effects	
of	 exchanging	 the	 zinc	 ion	 for	 V(III),	Mn(II),	 Co(II),	 Cu(II)	 and	 Cd(II)	 on	 the	 TbADH	
structure	and	enzymatic	properties.122	

















geometry	with	 the	 binding	 ligands,	 Cys46,	His67,	 Cys174	 and	 a	water	molecule.123	
Some	of	the	original	catalytic	activity	was	also	maintained	when	ethanol	was	used	as	
substrate.	 Substrate	 binding	 and	 activation	 investigations	 with	 trans-4-(N,N-
dimethylamino)cinnamaldehyde	 (DACA)	 revealed	 that	both	 the	dissociation	 rate	of	
DACA	and	the	hydride	transfer	rate	constant	were	correlated	with	the	expected	Lewis	
acidities	 of	 investigated	 metals,	 in	 the	 order	 Co(II)	 >	 Ni(II)	 ≥	 Zn(II)	 >>	 Cd(II).	 This	
indicated	 that	 the	 different	 catalytic	 behaviours	 observed	were	 a	 reflection	 of	 the	
different	 chemical	 properties	 of	 the	 metal	 ion	 introduced	 at	 the	 active	 site,	
emphasising	its	importance	on	the	kinetics	of	catalysis.	
In	support	of	the	above	conclusion,	replacement	of	the	zinc	ion	in	TbADH	with	Mn(II)	
and	 Co(II)	 resulted	 in	 enhanced	 activity	 (245	 %	 and	 130	 %	 of	 the	 initial	 activity,	
respectively),	 whilst	 replacement	 with	 Cd(II),	 Cu(II)	 and	 V(III)	 resulted	 in	 reduced	
activity	(20	%	for	Cd	and	<5	%	of	the	initial	activity	for	Cu	and	V).	These	results	were	




coordination	at	 the	metal	 active	 site	 in	Co-TbADH,	with	 the	 two	additional	 ligands	
believed	to	be	water	molecules.	Using	DMSO	as	a	substrate	model,	it	was	found	that	
the	coordination	number	remained	as	six	when	the	substrate	analogue	was	bound,	
with	 a	 small	 variation	 in	 the	 bond	 lengths	 between	 the	 zinc	 site	 with	 bound	 and	
unbound	 substrate	 (Figure	1.33).	 This	 change	 in	bond	 length	may	 result	 in	a	 slight	
conformational	 change	 upon	 substrate	 binding,	 resulting	 in	 a	 more	 favourable	
position	 for	 catalysis.	 It	 was	 suggested	 that	 the	 higher	 coordination	 number	 was	






Figure	 1.33.	 Hypothesised	 geometry	 of	 the	 catalytic	 metal	 site	 in	 Co-TbADH.	 Reproduced	 from	
Kleifield	et	al.	(2004).124	
Furthermore,	 the	 same	 group	 also	 suggested	 oxidation	 to	 Co3+	 due	 to	 the	
accumulation	of	additional	positive	charge	from	the	octahedral	coordination	at	the	
catalytic	site	DMSO	was	found	to	induce	a	distinct	change	in	the	catalytic	zinc	charge	
in	 native	 TbADH,	 which	 correlated	 to	 the	 formation	 of	 a	 pentacoordinated	
intermediate	 during	 catalysis.	Whereas	 in	 Co-TbADH,	DMSO	binding	 did	 not	 cause	
such	 changes,93	 suggesting	 it	 remained	 in	 an	 octahedral	 coordination	 throughout	
catalysis,	 displacing	 one	 of	 the	 ligands	 rather	 than	 adding	 as	 an	 extra	 ligand,	 as	



























Some	 enzymes	 naturally	 display	 reaction	 promiscuity.	 For	 example,	 Candida	
antarctica	lipase	B	(CALB)	has	been	observed	to	catalyse	an	array	of	transformations,	
in	 addition	 to	 its	 native	 hydrolysis	 and	 transacylation	 reactions.	 These	 additional	





This	 was	 accelerated	 by	 the	 tremendous	 advances	 in	 molecular	 biology,	
bioinformatics,	computational	modelling	and	protein	engineering	observed	in	the	past	
two	 decades.	 Genetic	modification	 at	 enzymatic	 active	 sites	 can	 be	 performed	 by	












hybrid	 of	 homogeneous	 and	 enzymatic	 catalytic	 approaches,129-131	 encompassing	
advantages	of	 the	 traditional	methods	 thus,	merging	 “the	best	 of	 both	worlds.”132	
They	rely	on	 the	 incorporation	of	a	catalytic	metal	complex	 into	a	macromolecular	
host,	such	as	a	protein.129	The	protein	host	acts	as	a	chiral	scaffold	and	is	therefore	
responsible	 for	 inducing	high	enantioselectivity	and	 for	allowing	 the	reaction	 to	be	
carried	 out	 in	 aqueous	 solution.	 The	metal	 catalyst	 determines	 the	 reactivity	 and	
reaction	 scope,	 allowing	 performance	 of	 non-natural	 reactions	 in	 a	 protein	 host.	
42	
	
Another	 benefit	 is	 the	 ease	 of	 modification	 of	 these	 artificial	 metalloenzymes	 by	





catalyst	 based	on	 a	 biotinylated	 rhodium	 complex	 incorporated	 into	 avidin	 (Figure	
1.34).	
	



































Figure	 1.35.	 General	 design	 of	 artificial	 metalloenzymes	 illustrating	 the	 different	 anchoring	
strategies.129	a)	dative,	b)	covalent	and	c)	non-covalent.		
of	a	defined	binding	site	within	the	protein	scaffold.129	This	strategy	usually	consists	in	
the	 removal	 of	 the	 catalytic	 active	 metal	 from	 an	 existing	 metalloenzyme	 and	
replacing	 it	 with	 a	 different	 metal	 ion,	 in	 order	 to	 enhance	 current	 activity	 or	 to	







incorporation	 of	metalloporphyrins	 containing	 the	 non-native	 Ir	 metal	 into	 heme-
dependent	proteins,	leading	to	the	catalysis	of	carbene	insertions	into	C-H	bonds.140	














both	 reported	 the	 replacement	 of	 the	 native	 zinc	 with	 manganese	 in	 carbonic	
anhydrase,	 a	 metalloenzyme	 which	 catalyses	 the	 hydration	 of	 carbon	 dioxide	 to	











amount	 of	 additional	 bound	 rhodium	 to	 2.3	 and	 1.8,	 respectively.	 These	 rhodium	
carbonic	 anhydrase	 complexes	 showed	 selectively	 reduced	 cis-stilbene	 over	 trans-



















suggested	 that	 Rh(I)	 bound	 at	 the	 active	 site	 of	 hCAII	 could	 catalyse	 the	 direct	
hydrogenation	of	CO2	to	formic	acid.	
1.3.2.3 Artificial	metalloenzymes	for	enantioselective	imine	reduction		
The	best	hybrid	catalytic	systems	reported	so	 far	 for	 the	reduction	of	 imines	come	
from	the	group	of	Ward	and	co-workers.	They	initially	reported	on	biotin-streptavidin	
catalysts	 containing	 Noyori-type	 complexes	 for	 ketone	 transfer	



























































anchors	 for	 the	 metal	 catalysts	 (Figure	 1.39).	 These	 presented	 lower	 turnover	






















Given	 the	 chemical	 similarity	 between	 ketone	 and	 imine	 substrates	 and	 their	
enzymatic	reduction	mechanisms,	it	is	surprising	that	no	ADHs	have	been	shown	to	
catalyse	 the	 reduction	 of	 imines.	 Several	 reasons	 can	 be	 identified	 for	 this.	 Imine	
substrates	or	 amine	products	might	 inhibit	ADHs,	 as	a	 result	of	 the	 strong	binding	
between	nitrogen	and	the	catalytic	zinc.	Imine	size	and	shape	may	also	be	an	issue,	
due	to	the	extra	substituent	bound	to	the	nitrogen	atom.	Finally,	imine	instability	in	



















This	 objective	 involves	 replication	 of	 the	 IRED	 active	 site	 within	 an	 ADH,	 by	
replacement	of	the	catalytic	zinc	ion	with	an	aprotic	residue	situated	within	range	of	
substrate	 interaction.	First,	the	choice	of	the	thermostable	TADH	from	Thermus	sp.	
will	 be	 justified,	 and	 reliable	methods	 for	 its	 expression	 in	E.	 coli,	 purification	 and	






























NAD+,	 NADH	 and	 4-chloronicotinic	 acid	 were	 purchased	 from	 Apollo	 Scientific	 Ltd	
(UK).	 HiTrap	 Q	 Sepharose	 High	 Performance	 (5mL),	 HiLoad	 Superdex	 200	 and	
disposable	PD-10	desalting	columns	were	from	GE	Healthcare.	4-Bromonicotinic	acid	




University	 of	 Technology	 (Netherlands)	 and	 its	 construction	 was	 previously	
described.108	To	confirm	 its	 integrity,	 sequencing	was	performed	by	Eurofins	MWG	
Operon	(Germany),	results	shown	in	Appendix	1.	
3.2 Instruments		






Protein	 chromatography	 was	 performed	 using	 an	 AKTA	 Fast	 Protein	 Liquid	
Chromatography	system	(GE	Healthcare)	and	monitored	by	absorbance	at	280	nm.		








MHz	 1H	 frequency,	 100	 MHz	 13C	 frequency)	 or	 DPX300	 instrument	 (300	 MHz	 1H	
frequency,	 75	MHz	 13C	 frequency).	 Chemical	 shifts	 are	 quoted	 in	 parts	 per	million	
(ppm),	 referenced	 to	 the	 residual	 deuterated	 solvent	 quoted	 in	 text	 as	 internal	






Protein	 sequences	 for	 IREDs	and	ADHs	were	obtained	 from	 the	RCSB	Protein	Data	
Bank	and	were	compared	via	sequence	alignment	performed	using	the	Clustal	Omega	























were	 prepared	 in	 deionised	water	 (dH2O)	 and	 stored	 at	 room	 temperature	 unless	
otherwise	 stated.	Where	 solid	medium	was	 required,	 agar	 (Melford;	 15	 g	 /	 L)	was	
added	to	the	medium	prior	to	autoclaving.	Antibiotics	were	prepared	as	a	1000	times	
concentrate	of	the	working	concentration:		chloramphenicol	solutions	(34	mg	/	mL)	







pLysS,	 growth	 and	 expression	 media	 contained	 carbenicillin	 (50	 µg	 /	 mL)	 and	
chloramphenicol	 (34	 µg	 /	 mL).	 When	 cells	 were	 BL21(DE3),	 the	 antibiotic	 was	
carbenicillin	(50	µg	/	mL).	All	cultivations	were	performed	in	Erlenmeyer	flasks,	with	






















































































	 	 	 0.24	=	0.4244	x	conc.	(mg	/	mL)	+	0.0345	
	 	 									conc.	(mg	/	mL)	=	(0.24	-	0.0345)	/	0.4244	
	 	 	 	 	 	=	0.484	mg	/	mL	
Thus,	non-diluted	sample	concentration	=	0.484	x	5	


























cyclohexanol.	 The	 following	 standard	 procedure	 is	 outlined	 with	 1-butanol.	 Any	
variations	in	enzyme	assay	parameters	are	highlighted	in	the	Results.		
The	reagents	and	cell	compartment	of	the	spectrometer	were	kept	at	60°C	prior	to	






linear	 rate	 of	 reaction	 (up	 to	 the	 initial	 300	 s).	 For	 all	 enzymatic	 assays,	 a	 control	
reaction	was	performed	replacing	the	enzyme	with	50	mM	Glycine-NaOH	buffer,	pH	
9.0	 (10	µL)	 following	NADH	absorbance	at	340	nm,	no	 increase	 in	absorbance	was	































































































concentration	 of	 50	 mM	 in	 milliQ	 water.	 Imine	 (2-methyl-1-pyrroline	 1,	 2,3-
dihydroisoquinoline	2)	and	ketone	(cyclohexanone)	stock	solutions	were	prepared	in	
a	concentration	of	1	M	in	acetonitrile	(or	other	organic	solvent	as	specified	in	text).	





















The	procedures	described	above	were	 repeated	 for	 the	Michaelis-Menten	kinetics,	



















Site-Directed	 Mutagenesis	 Kit	 (Agilent),	 and	 their	 DNA	 sequences	 confirmed	 by	
sequencing	 performed	 by	 Eurofins	 Genomics.	 Primers	 were	 designed	 using	 the	
QuikChange®	Primer	Design	Program	(Agilent)	and	purchased	from	Integrated	DNA	
Technologies.	Primer	sequences	for	each	mutation	can	be	found	in	Appendix	2.	





was	 then	 grown	 as	 described	 in	 section	 3.4.2.	 (LB	 media,	 37	 oC,	 200	 rpm)	 and	
expression	induced	at	30	oC	OD600	~0.8	with	IPTG	to	a	final	conc.	0.4mM.	Purification	
was	performed	by	heat	treatment	(80	oC,	20	min)	and	a	sample	taken	for	SDS-PAGE	





















pH	9.0	 50	mM	 860	 860	 -	
Enzyme	 0.2	mg	/	mL	 100	 100	 0.02	mg	/	mL	
Substrateb	 5	M	in	ACN	 20	 20	 100	mM	
ACN	 -	 20	 0	 2	%	
NAD+	 50	mM	 0	 20	 1	mM	
a	Assays	 run	at	340	nm,	60	 oC	 for	5	min;	 b	1-butanol	was	added	to	a	 final	conc.	of	100	mM	with	no	
addition	of	organic	solvents.	









Bis-Tris	pH	6.0	 50	mM	 Up	to	1	mL	 Up	to	1	mL	 -	
Enzyme	 0.2	mg	/	mL	 10	or	100	 10	or	100	 0.002	or			0.02mg	/	mL	
Substrateb	 1	M	in	ACN	 20	 20	 20	mM	
ACN	 -	 20	 0	 2	%	










Dialysis	 tubing	 (Sigma-Aldrich)	 (molecular	 cut-off	 =	 14	 kDa)	 was	 treated	 for	 the	
removal	of	traces	of	glycerol,	sulphides	and	heavy	metals.	Dialysis	tubing	was	washed	














Each	 dialysis	 step	 was	 carried	 out	 at	 4	 oC	 unless	 otherwise	 stated,	 against	 three	
changes	of	buffer	(100-500	volumes),	with	3	hours	between	first	two	buffer	changes	
and	overnight	 for	 the	 final	buffer	change.	Sample	solutions	of	TADH	(1-5	mg	/	mL,						
0.8-3	mL)	were	prepared	and	loaded	into	the	pre-soaked	dialysis	tubing.	The	sample	










































of	 buffer.	 Initial	 buffers:	 (20	 mM)	 MES	 pH	 6.0	 or	 pH	 6.5	 containing	 1,10-





























loading.	 The	 same	buffers	were	used	 for	 all	washes	and	buffer	exchanges.	 Sample	



















































otherwise	 stated.	 All	 aqueous	 solutions	 were	 prepared	 using	 deionised	 water.	
Analytical	 thin	 layer	 chromatography	was	 carried	 out	 on	 aluminium	backed	 plates	
coated	with	Merck	Kieselgel	60	GF254	and	visualised	under	UV	light	at	254	and	/	or	
360	 nm.	 Chemical	 staining	was	 also	 routinely	 used,	with	 aqueous	 basic	 potassium	
permanganate.	Flash	chromatography	was	carried	out	using	Davisil	silica	60	Å,	with	
the	eluent	specified.		












overnight.	 Aqueous	 K2CO3	 (2.0	M,	 20	 mL)	 was	 added	 and	 the	 aqueous	 layer	 was	









The	 procedure	 described	 above	 was	 used	 with	 5-bromonicotinic	 acid	 (1.0	 g,	 4.95	























































All	 manipulations	 were	 carried	 out	 using	 standard	 Schlenk	 techniques.	 The	
corresponding	 starting	material	 (1	 equivalent),	 imidazole	 (1.6	 equivalents),	 cesium	
carbonate	 (2.0	 equivalents)	 and	 copper(I)	 iodide	 (0.2	 equivalents)	 were	 mixed	 in	
deoxygenated	dimethylformamide	(8	mL)	and	heated	to	115-120	oC	under	dinitrogen	


























1H,	 pyridyl-H),	 7.73	 (t,	 J	 =	 1.4	 Hz,	 1H,	 imidazolyl-H),	 7.16	 (dd,	 J	 =	 1.4,	 0.9	 Hz	 1H,	
imidazolyl-H),	 3.77	 (s,	 br,	 2H,	 diisopropylamine-NCH),	 1.37	 (s,	 br,	 12H,	
diisopropylamine-CH3).	
































NCH),	 1.52,	 (d,	 J	 =	 6.8	 Hz,	 3H,	 diisopropylamine-CH3),	 1.42,	 (d,	 J	 =	 6.8	 Hz,	 3H,	
diisopropylamine-CH3),	1.05,	(d,	J	=	6.8	Hz,	3H,	diisopropylamine-CH3),	0.61	(d,	J	=	6.7	
Hz,	3H,	diisopropylamine-CH3).	
13C	NMR	 (100	MHz,	 (CD3)2CO-d6,	 298	 K):	dC	 (ppm)	 166.2	 (C=O),	 151.9	 (pyridyl-CH),	
149.6	(pyridyl-CH),	140.6	(imidazolyl-CH),	131.4	(imidazolyl-CH),	129.2	(imidazolyl-CH),	










































Hz,	 1H,	 pyridyl-H),	 7.51	 (t,	 J	 =	 1.4	 Hz,	 1H,	 imidazolyl-H),	 7.11	 (d,	 J	 =	 1.2	 Hz,	 1H,	
imidazolyl-H).	
13C	 NMR	 (100	MHz,	 (CD3)2SO-d6,	 298	 K):	dC	 (ppm)	 165.7	 (C=O),	 153.4	 (pyridyl-CH),	
151.5	 (pyridyl-CH),	 142.6	 (pyridyl-C),	 137.4	 (imidazolyl-CH),	 129.2	 (imidazolyl-CH),	
123.0	(pyridyl-C),	120.5	(imidazolyl-CH),	120.2	(pyridyl-CH).		
ESI+-MS:	190.1	([M+H]+,	100	%),	212.0	([M+Na]+,	37.2	%).	





























The	 procedure	 described	 above	 was	 used	 with	 5-(1	 H-imidazol-1-yl)-N,N-













































































N),	143.1	 (pyridyl-CH),	139.6	 (pyridyl-CH),	136.9	 (pyridyl-C),	136.4	 (pyridyl-C),	134.2	











































C),	 134.9	 (benzyl-C),	 130.8,	 130.6,	 130.5,	 130.0,	 129.8,	 (2	 x	 benzyl-CH),	 124.4	















































3H,	 benzyl-H	 x	 3),	 7.25	 –	 7.30	 (m,	 2H,	 benzyl-H),	 4.91	 (q,	 J	 =	 6.5	 Hz,	 1H,																							
-CHOHCH3),	1.50	(dd,	J	=	6.4,	0.5	Hz,	3H,	-CHOHCH3).		










1,2,3,4-tetrahydroisoquinoline:	 1H	NMR	 (400	MHz,	CDCl3-d,	 298K):	dH	(ppm)	
7.03	–	7.11	(m,	3H,	phenyl-H	x	3),	6.96	–	7.99	(m,	1H,	phenyl-H),	3.98	(s,	2H,	









was	 adjusted	 to	 pH	 8.0	 with	 NaOH.	 Substrate	 stock	 solutions	 were	 prepared	 by	













calculated	 as	 above,	 by	 integration	 of	 the	 methyl	 signals	 at	 2.61	 and	 1.50	 ppm,	
respectively.		







was	 adjusted	 to	 8.0	 with	 NaOH.	 Substrate	 stock	 solutions	 were	 prepared	 by	
solubilising	 the	 desired	 substrate	 (acetophenone,	 2-methyl-1-pyrroline	 and	 2,3-
dihydroisoquinoline)	in	ACN	to	a	final	concentration	of	50	mM.	The	iridium	complex	
was	 dissolved	 in	 degassed	 milliQ	 water	 containing	 ACN	 (5	 %	 v	 /	 v)	 to	 a	 final	
concentration	of	1.25	mM.	TADH	stock	solution	was	prepared	to	a	final	concentration	
































Bis-Tris	pH	6.0	 50	mM	 910	 910	 ~50	mM	
Enzyme	 0.56	mg	/	mL	 10	 10	 0.0056	mg	/	mL	
Substrate	 500	mM	 40	 40	 20	mM	
DMSO	 -	 20	 0	 2	%	
Ligand	21a	 0,	5,	12.5	mM	 0	 20	 0,	0.1,	0.25	mM	

























Bis-Tris	pH	6.0	 50	mM	 880	 880	 ~50	mM	
Enzyme	 0.56	mg	/	mL	 10	 10	 0.0056	mg	/	mL	
cyclohexanone	 500	mM	 40	 40	 20	mM	
ACN	 -	 50	 30	 5%	
Ir	complex	24a	 0,	2.5,	5	mM	 0	 20	 0,	0.05,	0.1	mM	











The	 enzymatic	 reduction	 of	 carbonyls	 is	 performed	 by	 well-described	 alcohol	
dehydrogenases	 (see	 section	 1.2).	 On	 the	 other	 hand,	 the	 enzymatic	 reduction	 of	
imines,	 which	 differ	 from	 carbonyls	 only	 by	 replacement	 of	 the	 oxygen	 with	 a	
substituted	nitrogen,	was	rarely	encountered	in	nature	until	recently;	when	the	class	
of	imine	reductases	(IREDs)	was	discovered	and	characterised.	Similar	to	ADHs,	IREDs	




Since	 the	 beginning	 of	 this	 thesis,	 the	 knowledge	 and	 application	 of	 IREDs	 to	
biotransformations	have	 increased	very	 rapidly.	However,	 there	are	still	 challenges	
associated	with	IRED	application	to	organic	synthesis.	In	comparison,	ADHs	are	better	







































• 	The	 zinc	 content	 in	 the	 TADH	 purified	 by	 heat	 treatment	 was	 lower	 than	
expected.	Purification	by	size	exclusion	chromatography	led	to	a	protein	:	zinc	
molar	ratio	of	1	:	1.6,	closer	to	the	expected	result.	






















substrate	 spectrum	was	 hypothesised	 to	 have	 increased	 chances	 to	 accept	
non-native	imines.		
• NADH	dependence.	Use	of	NADH	as	cofactor	was	preferred,	since	 it	 is	more	
available	and	cheaper	than	NADPH.	
• Available	 crystal	 structure.	 Well	 characterised	 ADHs	 allow	 for	 better	
understanding	of	the	structure	and	mechanistic	functions,	affording	informed	
decisions	on	protein	engineering.		







Table	 4.2.	 Comparison	 of	 desired	 criteria	 of	 potential	 ADHs	 for	 introduction	 of	 imine	 reductase	
activity.a		
	 HLADH	 ADH-A	 TbADH	 TADH	 TeSADH	 PpADH	 AdhA	
Thermostability	 O	 ü	 ü	 ü	 ü	 ü	 ü	
High	solvent	
stability	 O	 ü	 ü	 ü	 ü	 ü	 ü	
Broad	substrate	
range	 ~	 O	 O	 ü	 ü	 O	 ~	
NADH	
dependent	 ü	 ü	 O	 ü	 O	 ü	 O	
Available	crystal	
structure	 ü	 ü	 ü	 ü	 O	 O	 O	
E.	coli	expression	




One	 of	 the	 most	 studied	 ADHs	 is	 HLADH	 from	 horse	 liver.	 This	 NADH-dependent	
mesophilic	 enzyme	 accepts	 predominantly	 primary	 alcohols	 and	 aldehydes	 as	
substrates,	 although	 reduction	 of	 ketones	 was	 also	 described.	 HLADH	 was	 also	
reported	 to	 show	 some	 organic	 solvent	 tolerance.	 The	 limited	 substrate	 scope,	
thermal	stability	and	organic	solvent	 tolerance	of	HLADH	reduce	 its	applicability	 to	
organic	transformations.	In	addition,	recombinant	production	of	HLADH	from	E.	coli	
requires	 purification	 procedures	 that	 are	 not	 straightforward.	 Production	 of	 a	His-
tagged	 version	 of	 HLADH	 has	 been	 reported,	 however	 tentatives	 to	 reproducibly	
purify	this	construct	were	not	trivial	(Mattias	Basle,	unpublished	data).	
On	the	other	hand,	several	ADHs	with	 tolerance	 towards	organic	solvents	and	/	or	
possessing	 thermostability	 have	 been	 published.	 Amongst	 these,	 the	 best	
86	
	
characterised	 are	 Zn-dependent	 ADHs	 from	Rhodococcus	 ruber	DSM	 44541	 (ADH-
A),162	 Thermoanaerobacter	 brockii	 (TbADH),122	 Thermus	 sp.	 ATN1	 (TADH),163	
Thermoanaerobacter	ethanolicus	(TeSADH):164	as	well	as	non	metal-dependent	ADHs	
from	 Paracoccus	 pantotrophus	 DSM	 11072	 (PpADH)165	 and	 Pyrococcus	 furiosus	
(AdhA).161	Crystal	structures	have	also	been	published	for	the	Zn-dependent	enzymes	
excluding	TeSADH;	no	crystal	 structures	have	been	 reported	 for	either	of	 the	non-
metal	dependent	ADHs,	thus	they	were	ruled	out.	Half	of	these	enzymes,	 including	
TbADH	are	NADPH-dependent	and	were	therefore	not	considered	for	this	study.	Thus,	
leaving	 ADH-A	 from	Rhodococcus	 ruber	 and	 TADH	 from	 Thermus	 sp.,	 both	 NADH-











aspartate	 residue	 (Asp152)	 in	 TADH	 replaces	 Cys174	 in	 HLADH.	 Therefore,	 it	 was	




involved	 in	 the	 binding	 of	 the	 catalytic	 zinc(II)	 ion	 located	 in	 the	 active	 site,	 the	
remaining	four	are	bound	to	a	second	zinc(II)	ion	at	a	structural	site.	It	is	these	four	
neighboring	 cysteines	which	 could	 cause	 problems,	 if	 oxidised,	 forming	 disulphide	
bonds	with	one	another	which	can	drastically	change	the	conformation	of	the	enzyme	







Figure	 4.1.	 Alignment	 of	 TADH	 (PDB	 4CPD,	 green)	 and	 HLADH	 (PDB	 4XD2,	 cyan)	 active	 sites,	



































The	 effect	 of	 IPTG	 concentration	 on	 TADH	 expression	 was	 also	 investigated,	 as	
Winograd	et	al.	showed	that	reduction	of	IPTG	increased	protein	solubility,	preventing	
the	formation	of	 inclusion	bodies.168	A	slight	 increase	 in	both	soluble	and	 insoluble	
protein	concentration	was	observed	by	SDS-PAGE,	when	IPTG	was	lowered	from	1	mM	
to	 0.4	 mM	 final	 concentration	 during	 induction	 (Figure	 4.3a-b,	 lanes	 3-4	 &	 7-8).	
Expression	 also	 occurred	 in	 the	 absence	 of	 IPTG,	 as	 shown	 by	 SDS-PAGE	 of	 both	
soluble	and	insoluble	fractions	(Figure	4.3a-b,	lane	6).	This	might	be	due	to	the	two	












Literature	 reports	 do	 not	mention	 the	 amount	 of	 insoluble	 protein	 formed	 during	




































The	purity	was	 evaluated	by	 visual	 inspection	of	 the	 SDS-PAGE,	whilst	 the	 specific	
















than	 the	 reported	 one,	 which	 increased	 by	 33	 %	 after	 AEX	 treatment	 using	 a	













in	 different	 specific	 activities.	 Hollmann	 and	 co-workers	 reported	 an	 increase	 in	
specific	 activity	 when	 the	 purification	 temperature	 increased,	 perhaps	 due	 to	
increased	folding	and	formation	of	the	quaternary	structure.	This	phenomenon	has	
previously	 been	 observed	 with	 thermostable	 proteins	 expressed	 in	 E.	 coli.	 Similar	










compared,	 to	 assess	 whether	 TADH	 specific	 activity	 could	 be	 increased:	 anion	
exchange	(AEX)	and	size	exclusion	chromatography	(SEC).		
Table	4.3.	Effect	of	temperature	and	time	of	heating	on	the	specific	activity	of	TADH.	
Entry	 Temperature	(oC)	 Time	(min)	 Specific	activity	(U	/	mg)a	
1	 75	 15	 1.2	±	0.10	
2	 75	 20	 1.3	±	0.21	
3	 80	 20	 2.2	±	0.16	
4b	 80	 20	 1.6	±	0.10	
a	 TADH	was	 expressed	 in	 LB	medium,	 following	 induction	 with	 0.4	mM	 IPTG.	 Specific	 activity	 was	
determined	in	the	oxidative	direction	at	60	oC,	using	1-butanol	(100	mM)	as	a	substrate,	NAD+	(1	mM)	






purity.	 Unexpectedly,	 the	 largest	 peak	 obtained	 during	 SEC	 purification	 was	 not	
























longer	 time.	This	confirms	 that	 the	higher	purification	 temperature	might	promote	
better	 folding	 of	 the	 protein	 during	 purification.	 Further	 AEX	 purification	 did	 not	
increase	the	Zn	:	protein	ratio,	but	SEC	purification	resulted	in	an	increased	Zn	content,	
and	 suggested	 SEC	 as	 the	 optimal	 purification	 method	 (Table	 4.5).	 Nonetheless,	
purification	 by	 SEC	was	 not	 performed	 throughout	 the	 thesis,	 because	 the	 results	
above	were	obtained	after	initial	TADH	engineering	experiments	were	performed.	For	
much	of	the	following	studies	in	Section	4.3,	only	heat	purification	was	used,	which	
































Table	 4.6.	 Kinetic	 constants	 observed	 for	 cyclohexanol	 and	 cyclohexanone	 as	 compared	 to	 the	
reported	constants	found	in	the	literature.	
	 Kinetic	constants	 Reported	Value109	 Achieved	Value	
Oxidationa	 Vmax	(U	/	mg)	 20.78	±	0.55	 16.0	±	0.37	
	 KM	(mM)	 2.09	±	0.26	 1.5	±	0.11	
Reductionb	 Vmax	(U	/	mg)	 15.14	±	0.2	 7.3	±	0.11	


















content	 was	 observed	 to	 be	 an	 issue	 depending	 on	 the	 purification	 method.	 The	






at	 30	 oC,	 heat	 purification	 at	 80	 oC	 for	 20	 min,	 followed	 by	 size	 exclusion	
chromatography.	The	resulting	TADH	showed	specific	activity	of	6.0	U	/	mg	towards	
1-butanol	 and	 11.8	 U	 /	mg	 towards	 cyclohexanol,	 steady	 state	 kinetic	 parameters	
similar	to	the	ones	reported	in	the	literature,	and	a	Zn	content	which	was	lower	than	




















(Brønsted	 acid),	 which	 generally	 employ	 a	 tyrosine	 as	 part	 of	 a	 hydrogen	 bond	
network	tetrad	with	serine-lysine-asparagine.	Similar	to	short-chain	reductases,	IREDs	

















substrate-binding	 pocket	 or	 have	 the	 correct	 orientation	within	 the	 active	 site	 for	











the	 correct	 orientation	 for	 hydride	 transfer.	 Activity	 assays	with	 relevant	 ketones,	
inhibition	 assays	 and	 docking	 studies	 were	 used	 to	 gain	 understanding	 of	 the	






• TADH	 was	 demonstrated	 to	 maintain	 activity	 towards	 2-pentanone	 and	 2-
ethylbenzaldehyde,	albeit	this	was	much	reduced	compared	to	cyclohexanone.	
These	carbonyl	substrates	were	similar	in	size	to	the	corresponding	precursors	












Two	 cyclic	 imines	 and	 their	 reduced	 amine	 products	 were	 chosen	 as	 possible	
substrates	for	TADH,	as	they	were	shown	to	be	stable	under	aqueous	conditions,	and	
were	good	substrates	for	IREDs:	2-methyl-1-pyrroline	1	and	3,4-dihydroisoquinoline	










2-methyl-1-pyrroline 3,4-dihydroisoquinoline 2-methylpyrrolidine 1,2,3,4-tetrahydroisoquinoline









Before	 activity	 of	 TADH	 with	 selected	 substrates	 could	 be	 determined,	 a	 suitable	
solvent	 had	 to	 be	 found,	 to	 allow	 substrate	 solubilisation.	 This	 was	 particularly	
important	in	the	case	of	the	bulky	aldehyde	6.	The	activity	of	TADH	was	assessed	using	





study,	 the	 effect	 of	 acetonitrile	 (ACN),	 dimethylformamide	 (DMF)	 and	 dimethyl	
sulfoxide	(DMSO)	on	TADH	activity	was	investigated	at	different	concentrations.		
Initial	 assays	 were	 performed	 using	 1-butanol	 as	 the	 standard	 substrate	 in	 the	
oxidative	direction,	using	10	%	v	/	v	solvent,	to	ensure	solubilisation	of	the	substrates	































1	 1-butanol	 H2O	 10	 6.06	±	0.10	 100	
2	 1-butanol	 ACN	 10	 2.14	±	0.21	 35	
3	 1-butanol	 DMF	 10	 2.34	±	0.26	 39	
4	 1-butanol	 DMSO	 10	 2.87	±	0.29	 47	
5	 Cyclohexanol	 H2O	 5	 9.88	±	0.20	 100	































concentration	 in	 the	 mixture.	 This	 could	 be	 explained	 by	 the	 inhibitor	 behaviour	










































1	 H2O	 5	 15.9	±	0.37	 100	
2	 ACN	 2	 9.19	±	0.21	 58	
3	 DMF	 2	 2.40	±	0.19	 15	
4	 DMSO	 2	 6.59	±	0.21	 42	






ACN	which	was	 shown	 to	have	 little	 (>15	%)	 effect	 on	 the	oxidation	 reaction,	 and	
resulted	 in	 45	%	 and	 1	 %	 remaining	 activity,	 respectively,	 when	 compared	 to	 the	
activity	 obtained	 with	 cyclohexanol	 under	 the	 same	 conditions	 (Table	 4.9,	 entries										
1-3).	Similarly,	reduction	of	5	and	6	yielded	5	%	and	4	%	relative	activity	compared	to	
cyclohexanone,	 respectively	 (Table	 4.9,	 entries	 4-6).	 Previous	 literature	 reported	
relative	specific	activities	of	85	%	and	6	%	for	2-pentanol	oxidation	and	2-pentanone	
reduction,	 respectively,	 but	 these	 results	 were	 obtained	 in	 the	 absence	 of	 added	
organic	solvent.		
The	use	of	2-ethylbenzaldehyde	6	has	not	yet	been	reported	as	a	substrate	for	TADH,	














1	 cyclohexanol	 11.5	±	0.55	 100	
2	 2-pentanol	 5.13	±	0.19	 45	
3	 2-ethylbenzyl	alcohol	 0.12	±	0.007	 1	
4	 cyclohexanone	 9.19	±	0.21	 100	
5	 2-pentanone	 0.46	±	0.004	 5	













into	 the	 TADH	 binding	 pocket,	 no	 activity	 was	 observed	 in	 either	 reduction	 or	
oxidation	directions	when	the	corresponding	imines	(1	and	2)	or	the	respective	amines	
(3	and	4)	were	used	as	substrates.	To	further	confirm	whether	these	compounds	could	





Imines	 were	 added	 to	 cyclohexanone	 reduction	 activity	 assays,	 in	 equal	
concentrations	 to	 the	 substrate	 (20	 mM).	 The	 results	 showed	 that	 3,4-
dihydroisoquinoline	2	completely	inhibited	cyclohexanone	reduction,	while	2-methyl-
1-pyrroline	1	only	slightly	decreased	the	activity	(Figure	4.11).	When	the	concentration	
of	 1	was	 increased	 to	 50	 mM,	 an	 increased	 inhibition	 was	 observed.	 This	 result	











On	 the	 other	 hand,	 when	 amines	 3	 and	 4	were	 added	 to	 cyclohexanol	 oxidation	
activity	assays,	complete	inhibition	was	observed	with	both	amines	(Figure	4.12).	Even	
when	the	concentration	of	3	was	decreased	to	a	fifth	of	the	substrate	concentration	



























amine,	 (p)	 100	mM	1,2,3,4-tetraisoquinoline,	4	 (¾)	 100	mM	2-methylpyrrolidine,	3	 (¿)	 20	mM	2-
methylpyrrolidine,	3.	The	reported	absorbances	are	averages	of	triplicate	assays,	and	error	bars	(less	
than	2	%	error)	were	omitted	for	clarity.	
Overall,	 these	 results	 suggested	 that	 imines	and	 their	 reduced	amine	 counterparts	
could	act	as	inhibitors	of	TADH.	Imine	1	showed	a	dependence	of	the	inhibition	on	its	
concentration,	whilst	imine	2	and	both	amines	showed	complete	inhibition	under	the	
conditions	 tested.	 To	 gain	 a	 better	 understanding	of	 the	 type	of	 inhibition,	 kinetic	
studies	were	performed,	 in	the	presence	of	different	concentrations	of	2-methyl-1-
pyrroline	1	and	2-methyl-1-pyrrolidine	3	as	inhibitors.	These	inhibitors	were	chosen	




























4.2.3.2 Determination	 of	 kinetic	 constants	 of	 inhibition	 with	 imine	 and	 amine	
inhibitors	
Michaelis-Menten	 kinetics	 was	 determined	 for	 cyclohexanone	 reduction	 in	 the	
presence	 of	 10	 mM,	 25	 mM	 and	 50	 mM	 of	 1,	 and	 the	 results	 are	 presented	 as	
Lineweaver-Burk	plots	(Figure	4.13,	see	Appendix	5	for	Michaelis-Menten	plots).		
	










substrate	complex,	at	a	 site	which	 is	different	 from	the	substrate-binding	site.	The	
increase	in	KM	suggests	that	the	binding	of	the	free	enzyme	is	preferred.	The	decrease	
in	 Vmax	 suggests	 that	 the	 enzyme	 becomes	 inactive	 upon	 inhibitor	 binding.	 For	
example,	 the	 inhibitor	might	bind	 to	 the	active	 site	 Zn,	 but	without	occupying	 the	
substrate-binding	 pocket.	 Binding	 at	 the	 place	 of	 the	 nicotinamide	 ring	 cannot	 be	












































catalytic	 zinc,	 as	 a	 consequence	 of	 the	 more	 nucleophilic	 character	 of	 the	 amine	
nitrogen	compared	to	the	imine.	To	investigate	this	further,	Michaelis-Menten	kinetics	
was	determined	for	cyclohexanone	reduction	in	the	presence	of	1	mM,	5	mM	and	10	
mM	of	3,	and	 the	 results	are	presented	as	Lineweaver-Burk	plots	 (Figure	4.14,	 see	
Appendix	6	for	Michaelis-Menten	plots).			
The	 analysis	 of	 the	 results	 again	 suggests	 that	 2-methyl-1-pyrrolidine	3	acted	 as	 a	
mixed	inhibitor.	Enzyme	activity	(Vmax)	was	found	to	decrease	with	increasing	inhibitor	
concentration,	whereas	this	time	KM	seemed	to	slightly	decrease	(Table	4.11).	In	this	
case,	 the	 slight	decrease	 in	KM	 suggests	an	 increase	 in	 the	apparent	affinity	of	 the	
enzyme	 for	 the	 substrate,	 meaning	 that	 the	 inhibitor	 favours	 the	 binding	 of	 the	
enzyme-substrate	 complex.	 Again,	 the	 decrease	 in	 Vmax	 suggests	 that	 the	 enzyme	





Figure	 4.14.	 Lineweaver-Burk	 plot	 illustrating	 the	 inhibitory	 effect	 of	 2-methylpyrrolidine	 (3)	 on	
cyclohexanol	oxidation.	Specific	activities	were	calculated	from	the	enzymatic	activities	determined	in	
the	oxidative	direction	at	60	oC,	using	TADH	(3	µg),	cyclohexanol	(0.5,	1,	2,	4,	8,	12	mM)	as	substrate,	
NAD+	 (1	mM)	as	 cofactor,	 in	 50	mM	Glycine-NaOH	buffer	 pH	9.0	 containing	5	%	 v	 /	 v	ACN	with	2-
methylpyrrolidine,	3	as	inhibitor	at	concentration:	(l)	0	mM	,	()	1	mM,	(¾)	5	mM,	(¿)	10	mM.	










































catalytic	Zn(II)	 seems	plausible,	 the	 inhibition	mechanism	cannot	be	determined	at	
this	stage.	To	gain	further	insight	into	the	interaction	of	imines	and	amines	with	the	
active	site	of	TADH,	and	in	the	absence	of	structural	information	of	inhibitors	bound	











suitable,	 the	 1-phenylacetone	 substrate	 was	 docked	 inside	 the	 protein	 scaffold,	
following	the	parameters	previously	outlined	by	Man	et	al.163	Figure	4.15	shows	a	very	
similar	 substrate	 orientation	 was	 obtained,	 thus	 confirming	 that	 the	 docking	
procedure	used	here	was	suitable	for	further	application	to	other	organic	compounds.		
	
















Using	 a	 similar	 procedure,	 imines	 1	 and	 2	 were	 successfully	 docked	 into	 the	
hydrophobic	substrate	pocket	of	TADH	with	the	bound	cofactor	(Figure	4.16).	The	best	
poses	 (lowest	 binding	 energies)	 were	 obtained	 when	 the	 imines	 occupied	 the	
substrate-binding	pocket,	in	similar	orientations	to	the	ketone	substrate	(Figure	4.15).	













sticks)	 shown	via	dashed	 lines	 (grey)	a)	2-methyl-1-pyrroline	 (pink	 sticks)	b)	3,4-dihydroisoquinoline	
(cyan	sticks).		
Docking	in	the	presence	of	the	model	ketone	showed	the	lowest	energy	imine	binding	







(1)	 and	 3,4-dihydroisoquinoline	 (3)	 docked	 in	 the	 presence	 of	 substrate	 1-phenylacetone	 (green	
sticks).	a)	2-methyl-1-pyrroline	(pink	sticks);	b)	3,4-dihydroisoquinoline	(cyan	sticks).	Cofactor	shown	in	
orange	sticks	and	catalytic	zinc	ion	as	a	grey	sphere.	
These	 results	 can	 be	 used	 to	 provide	 an	 explanation	 for	 the	 experimental	 results	
observed	previously:	binding	of	the	imines	at	a	secondary	hydrophobic	binding	site,	
which	might	prevent	the	reaction	from	occurring.	
A	 third	 docking	 was	 performed,	 where	 imines	 1	 and	 2	 were	 docked	 in	 the	 TADH	
structure,	 from	 which	 the	 NADH	 cofactor	 was	 manually	 removed.	 Binding	 at	 the	
cofactor	 binding-site	 would	 explain	 the	 decreased	 activity	 observed	 during	 the	
inhibition	 studies,	 and	 could	 also	 influence	 substrate	 binding,	 thus	 explaining	 the	
variation	 in	 KM.	 Imine	 1	 docked	 outside	 the	 nicotinamide-binding	 pocket	 within	 a								










































line).	a)	 (R)-selective	Q2EQE0	 from	Streptomyces	kanamyceticus	 (PDB	3ZHB,	yellow	cartoon);	b)	 (S)-
selective	IRED	from	Streptomyces	sp.	GF3546	strain	(PDB	4OQY,	cyan	cartoon).	
The	two	(S)-selective	IREDs	for	which	crystal	structures	were	available	at	the	time	of	






Inspection	of	 the	 superimposed	 structures	 (Figure	4.20)	 showed	 little	 resemblance	


















sticks)	 and	 the	 C4	 of	 NADPH	 (yellow	 sticks);	 b)	 (S)-selective	 IRED	 from	 Streptomyces	 GF3546	 (cyan	


















Six	 possible	 sites	 remained	 available	 for	mutagenesis:	 Cys38,	 Ser40,	 His59,	 Phe85,	










(pKa	 10.5)	 and	 aspartic	 acid	 (pKa	 3.9),	 which	 are	 the	 two	 main	 functionalities	
responsible	 for	 substrate	 activation	 in	 IREDs.	 Before	 creating	 the	 desired	 mutant	
library,	 the	 catalytic	 zinc	 ion	 had	 to	 be	 completely	 removed,	 in	 order	 to	 avoid	 its	
interference	with	the	imine	substrate,	resulting	in	inhibition	of	the	reaction.	All	three	








Catalytic	 zinc	 ion	 represented	with	 a	 grey	 sphere	 and	NADH	with	 orange	 sticks;	 a)	 Six	 remaining	
residues	 highlighted	 as	 possible	 candidates	 for	 mutagenesis.	 b)	 Model	 substrate,	 1-Phenylacetone	
(yellow	 sticks)	 docked	 into	 TADH	 active	 site	 using	 Autodock	 Vina.	 The	 distances	 of	 the	 closest	 and	
farthest	away	of	the	six	residues	to	the	oxygen	of	the	ketone	is	highlighted	with	grey	dashed	lines.	A	









The	 three	 single	mutants	 of	 TADH	 (C38A,	H59A	 and	D152A)	were	 created	 by	 site-
directed	mutagenesis.	 They	 were	 expressed	 and	 purified	 from	 250	mL	 expression	
Figure	 4.24.	 Model	 of	 TADH	 ‘zinc	 free’	 active	
with	2-methyl-1-pyrroline	(pink	sticks)	and	3,4-	
dihydroisoquinoline	 (cyan	 sticks)	 docked	 using	
Autodock	vina.	The	selected	residues	to	undergo	









SDS-PAGE	 and	 protein	 concentration	 analyses	 of	 the	 heat-purified	 TADH	 mutants	
























1	 WT	 5.95	 4.64	 100	
2	 D152A	 2.38	 0.06	 1	
3	 H59A	 2.31	 0.06	 1	
4	 C38A	 2.75	 0.05	 1	
a	WT	and	mutant	TADH	was	expressed	in	250	mL	cultures	in	LB	medium,	following	induction	with	0.4	
mM	IPTG,	as	described	in	Section	3.1.	The	protein	was	purified	by	heating	at	80	oC	for	20	min.	Protein	





The	 residues	 selected	 for	 changing	 to	 tyrosine	 and	 aspartate	 were	 Ser40,	 His59,	
Phe85,	 Asp152,	 Val108	 and	 Val268.	 All	 corresponding	 variants	 were	 designed	 to	
contain	the	initial	single	mutation	C38A	for	zinc	removal.	Given	that	aspartic	acid	is	














Figure	 4.26.	 Expression	 yields	 of	mutant	 and	wild-type	 TADH	presented	 as	 protein	 concentration	
(mg/mL)	in	lysis	buffer	8	mL.		
Each	 of	 the	 16	 mutants	 were	 investigated	 for	 IRED	 activity	 in	 the	 reduction	 and	
oxidation	directions	using	2-methyl-1-pyrroline	1	and	3,4-dihydroisoquinoline	2,	and	
their	 corresponding	 amines	 as	 substrates.	No	 activity	was	observed	 for	 any	of	 the	










































ability	 of	 TADH	 to	 accept	 the	 common	 5-membered	 or	 6-membered	 cyclic	 imine	
architecture	into	the	substrate-binding	pocket,	the	activity	of	TADH	was	determined	
with	two	carbonyl	substrates,	2-pentanone	and	2-ethylbenzaldehyde,	and	with	their	
corresponding	 reduced	 alcohols.	 These	 substrates	 were	 chosen	 because	 their	
structures	 were	 similar	 to	 the	 ones	 of	 common	 cyclic	 imine	 substrates	 used	 with	
IREDs.	TADH	showed	activity	with	both	these	substrate	architectures,	albeit	a	greatly	
reduced	 activity	 was	 observed	 with	 2-ethylbenzaldehyde	 (4	 %	 remaining	 activity	
compared	to	cyclohexanone),	and	 less	 than	half	 remaining	activity	with	2-pentanol	
(compared	 to	 cyclohexanol).	 Nonetheless,	 these	 results	 demonstrated	 that	
architectures	similar	to	the	cyclic	imine	substrates	could	fit	into	the	active	site.	
Two	cyclic	imines	and	their	reduced	amine	counterparts	were	tested	as	inhibitors	of	
TADH	 in	 the	 reductive	 and	 oxidative	 directions,	 respectively.	 TADH	 activity	 was	
completely	 inhibited	 by	 both	 3,4-dihydroisoquinoline	 2	 and	 its	 corresponding								
amine	4,	when	used	 in	the	same	concentration	as	the	substrate.	 Inhibition	kinetics	
were	determined	with	the	5-membered	imine	1	and	the	reduced	amine	3,	and	showed	
that	 both	 these	 compounds	 behaved	 as	 mixed	 inhibitors	 of	 TADH.	 This	 result	
suggested	 that	 imine	 and	 amine	 inhibitors	 occupy	 a	 different	 location	 from	 the	
substrate-binding	site,	but	their	binding	prevents	the	reaction	to	occur.	For	example,	
as	illustrated	with	the	docking	studies	they	might	bind	at	the	place	of	NADH,	and	/	or	
bind	elsewhere	 in	 the	 substrate	pocket.	 The	amine	 compound	was	 shown	 to	have	
inhibitory	effect	at	 lower	concentrations	compared	 to	 the	 imine,	 thus	suggesting	a	
possible	interaction	with	the	catalytic	zinc.	
The	combined	inhibition	and	docking	results	suggested	that	imines	could	in	principle	












the	carbonyl	and	 imine	bond,	 it	 seems	 the	differences	 in	 their	 chemical	properties	
dictate	 their	 reactivity.	 For	 example,	 the	 reduction	 potential	 of	 an	 imine	 is	 less	





imines	 and	 ketones	 can	 react	 in	 a	 similar	 fashion,	 for	 example,	 under	 nucleophilic	
attack	the	conditions	under	which	they	react	differ.	Imines	usually	require	a	stronger	
nucleophile	or	more	forceful	conditions	due	to	the	differences	in	electronegativity	of	
oxygen	 and	 nitrogen,	 the	 double	 bond	 in	 imines	 is	 less	 polarised	 and	 thus	 less	












native,	 chemical	 complexes	 within	 protein	 scaffolds.174,175	 This	 approach	 relied	 on	
building	artificial	metal	binding	sites,	by	using	a	linker	to	connect	the	metal-binding	
ligand	to	the	protein	(see	Section	1.3.2.3).	The	flexibility	of	the	linker-ligand	construct	
resulted	 in	 less	 control	 over	 the	 exact	 positioning	 of	 the	 metal.	 An	 alternative	
approach	 consists	 in	 the	 direct	metal	 incorporation	 within	 native	 binding	 sites,	 in	




this	 method,	 Kazlauskas	 and	 co-workers	 prepared	 rhodium(I)-containing	 carbonic	

















Previous	 studies	 reported	 that	 zinc	 can	 be	 replaced	 by	 other	metals	 in	 ADHs	 (see	
Section	1.2.6).	 Crystallographic	 studies	 of	 Co-,	 Ni-	 and	 Cd-HLADH	 showed	 that	 the	









ADH	binding	site	and	can	modulate	 its	catalytic	behaviour.	 It	 should	be	noted	 that	
none	 of	 the	 reconstituted	 ADHs	 mentioned	 above	 were	 investigated	 for	 novel	
reactivities.	Moreover,	no	examples	were	published,	where	late	transition	metals	such	
as	Ru,	Rh,	Ir	were	introduced	within	ADH.		
Additionally,	 encouraging	 reports	 were	 published,	 where	 rhodium(I)	 was	 used	 to	
replace	 zinc(II)	 in	 human	 carbonic	 anhydrase	 (see	 Section	 1.3.2.2).149,177	 Zinc(II)	
removal	 was	 performed	 by	 dialysis	 against	 a	 chelating	 agent,	 such	 as	 2,6-
pyridinedicarboxylate,	and	 rhodium	was	 inserted	 into	 the	 resulting	apo	enzyme	by	
dialysis	against	a	Rh(I)	salt.	Unspecific	binding	of	rhodium	to	surface	histidines	was	




promiscuity	 in	 metalloenzymes,	 by	 exchanging	 native	 with	 non-biological	 metals,	
which	are	not	readily	available	to	enzymes	in	nature.	
This	 section	 outlines	 the	 attempts	 to	 replace	 the	 catalytic	 zinc	 ion	 in	 TADH	 with	
rhodium,	in	an	effort	to	introduce	imine	reductase	activity	into	TADH.	Several	samples	





might	 not	 contain	 zinc	 and	 thus	 might	 not	 be	 properly	 folded.	 Size	 exclusion	
chromatography	was	used	as	the	purification	method163	and	the	resulting	secTADH	












Despite	 the	 low	 zinc(II)	 content	 for	 htTADH	 these	 samples	 were	 subjected	 to	
preliminary	zinc	removal	investigations.	The	low	zinc(II)	content	was	not	an	issue	as	
the	initial	criteria	for	success	was	recovery	of	native	activity,	after	zinc	removal	(loss	
of	 activity.)	As	 the	 recovery	of	 activity	 is	only	possible	as	 a	 result	of	 reinsertion	of	
























were	 developed	 for	metal	 exchange	 in	 both	HLADH1,16	 and	 TbADH6,9	 and	 included	
removal	 of	 zinc	 with	 1,10-phenanthroline	 (OPA),	 2,6-pyridinedicarboxylate	 or	
dipicolinic	acid	(DA),	ethylenediaminetetraacetic	acid	(EDTA)	and/or	mixtures	of	these	
chelators	in	a	range	of	concentrations,	up	to	20	mM.	The	main	method	reported	for	
metal	 exchange	 was	 dialysis	 and	 thus	 has	 been	 chosen	 for	 investigations	 of	 zinc	
removal	and	metal	reinsertion	in	TADH,	as	shown	in	Figure	4.28.	
The	main	challenge	of	this	work	is	the	presence	of	both	a	catalytic	and	a	structural	zinc	
in	 the	 protein	 structure.	 The	 removal	 of	 catalytic	 zinc	 only	would	 result	 in	 exactly										
50	%	zinc	loss,	which	was	the	target	for	apo-TADH.	Given	the	similarities	between	the	






Additionally,	 a	 previous	 report	 showed	 that	 in	 the	 absence	 of	 structural	 zinc,	 a	









was	 that	 successful	 removal	 of	 all	 catalytic	 zinc	 would	 result	 in	 complete	 loss	 of	
catalytic	activity,	and	a	loss	of	≥50	%	of	the	initial	amount	of	zinc.		
The	 three	 chelating	 agents	 identified	 from	 the	 literature	 were	 investigated	 at	
concentrations	5	mM	and	15	mM	for	the	removal	of	zinc	and	creation	of	apo-TADH.	












































containing	20	µM	Zn2+),	 to	 reconstitute	Zn-TADH.	After	 removal	of	excess	zinc,	 the	
specific	 activity	 and	 the	 zinc	 content	 of	 the	 resulting	 protein	 were	 assayed	 as	
described	above.	A	control	experiment	was	performed,	to	assess	the	stability	of	TADH	
under	 prolonged	dialysis,	 including	 the	 effect	 of	 the	 dialysis	 in	 the	 absence	 of	 the	
chelators	on	zinc	removal.	The	control	showed	22	%	loss	in	protein	concentration,	0	%	








increase	 in	 EDTA	 concentration	 was	 less	 effective	 (Table	 4.14,	 entries	 9	 and	 11).	










when	5	mM	OPA	and	15	mM	DA	were	used	 to	prepare	 the	apo-TADH,	and	 the	Zn	
content	also	increased,	equal	or	above	the	initial	value	(Table	4.14,	entries	2	and	8).	
On	the	other	hand,	no	activity	was	restored	when	EDTA	was	used	as	chelator,	despite	
















	 Control	 htTADH	 5.1	mg	/	mL	 1.3	U	/	mg	 Protein	:	Zn	1	:	0.79	
1	 5	mM	OPA	 Apo-TADH	 40	 71	 75	
2	 5	mM	OPA	 Zn-TADH	 75	 96	 126	
3	 15	mM	OPA	 Apo-TADH	 33	 100	 110	
4	 15	mM	OPA	 Zn-TADH	 92	 73	 95	
5	 5	mM	DA	 Apo-TADH	 95	 100	 116	
6	 5	mM	DA	 Zn-TADH	 100	 89	 106	
7	 15	mM	DA	 Apo-TADH	 100	 35	 51	
8	 15	mM	DA	 Zn-TADH	 91	 98	 96	
9	 5	mM	EDTA	 Apo-TADH	 100	 55	 59	
10	 5	mM	EDTA	 Zn-TADH	 60	 58	 111	
11	 15	mM	EDTA	 Apo-TADH	 73	 79	 73	
12	 15	mM	EDTA	 Zn-TADH	 83	 68	 71	















other	 hand,	 significant	 loss	 in	 protein	 concentration	 was	 observed	 upon	 OPA	
treatment,	although	encouragingly	some	protein	was	recovered	upon	zinc	reinsertion.	









To	 optimise	 preliminary	 results,	 different	 pH,	 chelator	 concentrations	 and	
combinations,	 as	 well	 as	 temperature	 conditions	 were	 tested.	 Zinc	 reinsertion	
experiments	were	systematically	performed	with	all	apo-TADH	samples,	to	determine	
if	 the	 enzymes	 could	 be	 reactivated	 or	 if	 loss	 of	 activity	was	 a	 sign	 of	 irreversible	
denaturation.		
4.3.3.1 Impact	of	pH	on	zinc	removal		
When	 the	 initial	 promising	 experiments,	 using	 OPA	 and	 DA	 as	 chelators,	 were	
repeated	on	a	 larger	 scale	using	a	more	diluted	protein	 sample	 (1.3	mg	/	mL),	 the	
results	obtained	for	Zn	removal	and	reinsertion	were	not	entirely	reproducible	(Table	
4.15,	entries	1-4).		In	particular,	removal	of	zinc	using	15	mM	DA	resulted	in	a	higher	
specific	 activity,	 but	 also	 in	 significant	 protein	 loss,	 between	 50-60	 %,	 which	 was	
observed	 in	 the	 dialysis	 tubing	 within	 the	 first	 3	 hours.	 Some	 protein	 could	 be	







amount	 of	 precipitation	 was	 observed,	 which	 could	 not	 be	 recovered	 after	 zinc	
reinsertion	(Table	4.15,	entries	5-6).		






















At	 pH	 6.5,	 zinc	 removal	 between	 38-58	 %	was	 observed	 and	 specific	 activity	 was	
almost	totally	removed,	once	again	suggesting	removal	of	catalytic	zinc	(Table	4.16,	
entries	5-6).	However,	large	differences	were	obtained	between	replicates,	suggesting	

















1	 5	mM	OPA	 Apo-TADH	 5.5	 20	 74	 50	
2	 5	mM	OPA	 Zn-TADH	 6.5	 70	 69	 129	
3	 15	mM	DA	 Apo-TADH	 5.5	 47	 61	 59	
4	 15	mM	DA	 Zn-TADH	 6.5	 70	 61	 105	
5	 5	mM	OPA	+	15	mM	DA	 Apo-TADH	 5.5	 33	 27	 55	
6	 5	mM	OPA	+	15	mM	DA	 Zn-TADH	 6.5	 49	 51	 105	
7	 5	mM	OPA	 Apo-TADH	 6.5	 91	 89	 63	
8	 5	mM	OPA	 Zn-TADH	 7.5	 94	 95	 141	
9	 15	mM	DA	 Apo-TADH	 6.5	 82	 34	 52	





dialyses	 were	 performed	 at	 4	 oC.	 The	 control	 sample	 htTADH	was	 at	 kept	 at	 4	 oC	 throughout	 the	
experiment	(96	h).	The	control	showed	98	%	protein	concentration,	62	%	specific	activity	and	100	%	
zinc	 compared	 to	 the	 non-dialysed	 protein	 at	 the	 beginning	 of	 the	 experiment.	 Experiments	 were	
performed	on	a	scale	of	2.5	mL	sample.		Percentages	are	given	compared	to	the	control.	Samples	were	
analysed	directly	after	dialysis;	 b	Expected	 zinc	occupancy	 is	1.0	 :	 2.0	 (protein	 :	 Zn	molar	 ratio),	 the	
control	had	only	40	%	of	the	expected	zinc	occupancy.			
Additionally,	 the	 pH	 of	 the	 buffer	 seemed	 to	 influence	 the	 amount	 of	 protein	
precipitation,	with	the	higher	pH	resulting	in	more	protein	being	recovered.	On	the	



















1	 10	mM	OPA	 Apo-TADH	 6.0	 54	 19	 47	
2	 10	mM	OPA	 Zn-TADH	 6.5	 85	 91	 113	
3	 10	mM	OPA	+	20	mM	EDTA	 Apo-TADH	 6.0	 78	 2	 62	
4	 10	mM	OPA	+	20	mM	EDTA	 Zn-TADH	 6.5	 80	 100	 137	
5	 10	mM	OPA	+	20	mM	EDTA	 Apo-TADH	 6.5	 51-69	 3-7	 38-58	
6b	 10	mM	OPA	+	20	mM	EDTA	 Zn-TADH	 7.5	 45-62	 89-153	 163-217	









are	 given	 compared	 to	 the	 control.	 Analyses	 of	 protein	 concentration,	 specific	 activity	 and	 Zn	
concentration	were	performed	after	centrifugation	of	the	samples;	b	Expected	zinc	occupancy	is	1.0	:	
2.0	(protein	:	Zn	molar	ratio),	the	control	had	only	40	%	of	the	expected	zinc	occupancy.		
To	 differentiate	 between	 protein	 loss	 as	 a	 result	 of	 pH	 and	 protein	 loss	 due	 to	
treatment	 with	 chelating	 agents,	 occurrence	 of	 protein	 precipitation	 was	 visually	
inspected	after	dialysis	of	the	protein	in	buffers	at	pH	5.5,	6.0	and	6.5.	Precipitate	was	








To	 account	 for	 any	 protein	 precipitate	 formed	 during	 dialysis	 and	 to	 ensure	 that	
analyses	 were	 performed	 on	 soluble	 protein,	 which	 was	 likely	 to	 remain	 folded,	
dialysis	 experiments	were	 repeated	with	 individual	 chelators	 at	 pH	 6.5.	 Instead	 of	
directly	 analysing	 samples	 after	 dialysis,	 centrifugation	 was	 performed	 and	 any	
insoluble	pellet	was	removed.	This	also	meant	that	no	resolubilisation	of	the	protein	
could	be	achieved.	With	5	mM	OPA,	some	differences	were	observed	compared	to	the	

















1	 5	mM	OPA	 Apo-TADH	 98	 50	 100	
2	 5	mM	OPA	 Zn-TADH	 99	 68	 118	
3	 15	mM	DA	 Apo-TADH	 75	 49	 51	
4	 15	mM	DA	 Zn-TADH	 48	 72	 137	





























removal	 at	 both	 room	 temperature	 and	60	 oC.	 Room	 temperature	was	 chosen	 for	





occurred	 in	all	cases	and	 little	resolubilisation	could	be	seen,	 in	particular	at	60	oC.	
Similar	to	previous	results	at	4	oC,	the	zinc	concentration	obtained	after	reinsertion	
























1	 Room	temperaturec	 Apo-TADH	 51-72	 5-16	 27-74	
2	 Room	temperaturec	 Zn-TADH	 62-89	 80-188	 59-392	
3	 60	oC	 Apo-TADH	 29	 25	 57	

































ICP-MS	analysis	showed	an	 increased	cobalt	content,	as	well	as	a	slight	 increase	 in	



























Figure	 4.29.	 SDS-PAGE	 of	 protein	
samples	 throughout	 metal	 exchange.	
Protein	 samples	 purified	 via	 heat	
treatment	 (80	 oC,	20	min)	and	 sent	 for	











Although	 the	 reconstituted	 protein	 possessed	 double	 the	metal	 content	 from	 the	




dialysed	 against	 a	 cobalt(II)	 solution	 under	 the	 same	 buffer	 and	 temperature	
















and	 activity	 recovery	 was	 obtained.	 However,	 all	 the	 results	 presented	 above,	
particularly	 for	 zinc	 reinsertion,	 showed	 inconsistencies	 between	 protein	
140	
	










Removal	 and	 reinsertion	 of	 zinc	 into	 the	 secTADH	 purified	 by	 size	 exclusion	




























	 Controlb	 secTADH	 0.34	mg	/	mL	 8.3	U	/	mg	 Protein	:	Zn	1	:	1.6	
1	 10	mM	OPA	 Apo-TADH	 100	 44	 38	
2	 10	mM	OPA	 Zn-TADH	 n.d.	 72	 113	
3	 10	mM	OPA	+	20	mM	EDTA	 Apo-TADH	 94	 74	 50	
4	 10	mM	OPA	+	20	mM	EDTA	 Zn-TADH	 89	 96	 169	
	 Controlc	 secTADH	 0.58	mg	/	mL	 4.4	U	/	mg	 Protein	:	Zn	1	:	1.5	
5	 10	mM	OPA	+	20	mM	EDTA	 Apo-TADH	 92	 1	 13	
6	 10	mM	OPA	+	20	mM	EDTA	 Zn-TADH	 62	 42	 93	
a	Apo-TADH	was	prepared	by	dialysing	secTADH	against	20	mM	MES	pH	6.0	containing	chelating	agents;	










was	 repeated	 using	 a	 newly	 prepared	 batch	 of	 TADH	 prepared	 under	 the	 same	
conditions	as	highlighted	in	section	3.4,	purifying	via	heat	treatment	(80	oC,	20	min)	
and	size	exclusion	chromatography,	with	slightly	different	characteristics.	This	time,	
the	 expected	 almost	 complete	 loss	 of	 specific	 activity	was	 observed	 (1	%	 residual	
activity),	however	much	of	the	zinc	seemed	to	be	lost	as	well,	indicating	removal	of	
the	structural	zinc.	This	was	also	suggested	by	only	a	partial	restoration	of	catalytic	






These	 results	 suggested	 that	 the	dialysis	method	applied	 for	 zinc	 removal	was	not	
reproducible,	and	might	have	promoted	the	removal	of	structural	zinc.	The	removal	
of	 the	 zinc	 was	 never	 complete,	 even	 when	 specific	 activity	 was	 fully	 abolished,	
suggesting	that	one	of	the	zinc-binding	sites	were	more	stable.	Throughout	this	work,	




metal	 removal	 and	 reinsertion,	with	 loss	 in	protein	 stability	during	 this	 time	when	
stored	at	4	oC.	Protein	precipitate	was	observed	in	the	control	with	a	total	protein	loss	






exchange	 were	 published	 by	 Maret	 et	 al.	 for	 cobalt	 substitution	 in	 HLADH.117	
Additionally,	others	have	also	reported	Rh	insertion	into	apo	carbonic	anhydrase	by	
























	 Control	 secTADH	 2.1	mg	/	mL	 3.2	U	/	mg	 Protein	:	Zn	1	:	1.5	
1	 10	mM	OPA	 Apo-TADH	 66	 22	 73	
2	 10	mM	OPA	 Zn-TADH	 75	 21	 120	
3	 10	mM	OPA	+	20	mM	EDTA	 Apo-TADH	 61	 47	 20	








Experiments	were	performed	on	a	 scale	of	2.5	mL	sample.	 	Percentages	are	given	compared	 to	 the	
control.		



















are	 less	 accessible	 to	 the	 chelator.	Conditions	 for	 the	 crystallisation	of	 TADH	were	
published	during	the	course	of	this	thesis	by	Man	et	al.,18	and	employed	0.1	M	Bis-Tris	
buffer	pH	6.5	containing	1	M	sodium	chloride	and	1.5	M	ammonium	sulphate.	Moving	
forward,	 further	 attempts	 at	 the	 creation	 of	 apo-TADH	 could	 be	 made,	 with	 a	









































	 Controlc	 secTADH	 0.34		mg	/	mL	
8.3		
U	/	mg	 	 1	:	1.6	:	0	
1	 OPA	 Apo-TADH	 100	 44	 38	 1	:	0.6	:	0	
2	 OPA	 Rh-TADH	 100	 15	 88	 1	:	1.4	:	6.5	
3	 OPA	+	EDTA	 Apo-TADH	 94	 74	 50	 1	:	0.8	:	0	
4	 OPA	+	EDTA	 Rh-TADH	 83	 26	 156	 1	:	2.5	:	24.0	
	 Controld	 secTADH	 0.58		mg	/	mL	
4.4		
U	/	mg	 	 1	:	1.5	:	0	
5	 OPA	 Apo-TADH	 72	 6	 60	 1	:	0.9	:	0	
6	 OPA	 Rh-TADH	 82	 2	 80	 1	:	1.2	:	1.7	
7	 OPA	+	EDTA	 Apo-TADH	 92	 1	 13	 1	:	0.2	:	0	
8	 OPA	+	EDTA	 Rh-TADH	 63	 32	 27	 1	:	0.4	:	2.6	
a	Apo-TADH	was	prepared	by	dialysing	secTADH	against	20	mM	MES	pH	6.0	containing	chelating	agents;	
excess	 chelators	were	 removed	 by	 dialysis	 against	 20	mM	MES	 pH	 6.5.	 Rh-TADH	was	 prepared	 by	
dialysing	 apo-TADH	 against	 20	mM	MES	 pH	 6.5	 containing	 20	 μM	Rh(I)(acac)(CO)2,	excess	 zinc	was	
removed	by	dialysis	against	20	mM	MES	pH	6.5.	All	dialyses	were	performed	at	4	oC.	The	control	sample	











with	 the	OPA	+	 EDTA	mixture	 presented	 a	 somewhat	 encouraging	 result.	 The	 zinc	
content	was	still	observed	to	increase	from	1	:	0.2	to	1	:	0.4	protein	:	Zn	content,	which	
was	much	 less	 than	 previously	 observed	 (Table	 4.23,	 entry	 4	 vs.	 8).	 The	 protein	 :	






On	 the	 contrary,	 the	 insertion	 of	 rhodium	 into	 the	 apo-TADH	prepared	 by	 dialysis	











stage	 it	was	 impossible	to	ascertain	whether	the	Rh	was	present	at	 the	active	site.	
When	OPA	+	EDTA	were	used	as	chelating	agents,	little	Rh	binding	and	little	activity	
were	observed.	These	results	were	treated	with	caution,	because	of	the	poor	results	
















	 Control	 secTADH	 2.1		mg	/	mL	
3.2		
U	/	mg	 	 1	:	1.5	:	0	
1	 OPA	 Apo-TADH	 66	 22	 73	 1	:	1.1	:	0	
2	 OPA	 Rh-TADH	 91	 36	 60	 1	:	0.9	:	0.9	
3	 OPA+EDTA	 Apo-TADH	 61	 47	 20	 1	:	0.3	:	0	












enzyme	 concentration,	 and	 thus	 of	 rhodium,	 was	 unsuccessful	 as	 well.	 Without	
further	 investigations	on	the	localisation	of	Rh	within	TADH,	 it	 is	difficult	to	predict	
how	 to	 optimise	 this	 result.	 Before	 engaging	 in	 any	 further	 investigations	 it	 is	
important	 to	have	a	well-defined	coordination	environment	 in	 the	Rh-TADH.	Given	
the	difficulties	to	obtain	a	robust	method	for	the	preparation	of	both	apo-TADH	and	
metal-TADH,	whether	with	 Zn,	 Co	 or	 Rh,	 no	 further	work	 has	 been	 performed	 on	





using	 the	 thermostable	 TADH.	 The	 analysis	 was	 complicated	 by	 the	 fact	 that	 the	
















Cobalt(II)	was	also	 inserted	 into	apo-TADH	and	 resulted	 in	 recovery	of	 the	 specific	
activity	to	82	%	of	the	initial	zinc-containing	protein.	However,	metal	content	analysis	




















applied	 to	 imine	 reduction.	 A	 second	 strategy	 was	 adopted,	 which	 consisted	 in	
designing	and	synthesising	a	non-native	binding	site,	to	be	incorporated	into	TADH.	
Two	methods	 have	 been	 described	 for	 the	 bioconjugation	 of	 a	 non-native	metal-
binding	 site	 to	 a	 protein:	 direct	 covalent	 attachment	 to	 a	 reactive	 side-chain,	 e.g.	
cysteine	thiol	group;	and	attachment	to	a	molecule	with	high	affinity	for	the	protein,	
e.g.	an	inhibitor	or	a	cofactor,	which	can	be	inserted	into	a	defined	binding	pocket	by	
supramolecular	 anchoring.	 Using	 this	 strategy,	 Ward	 et	 al.	 designed	 biotinylated	






TADH.	 The	 metal	 complex181	 would	 act	 as	 the	 hydrogen	 transfer	 catalyst,	 in	 the	
presence	 of	 a	 stoichiometric	 hydrogen	 source,	 similar	 to	 chemical	 transfer	
hydrogenation	catalysis.	
Highlights	



















experiments	 excluded	 the	 presence	 of	 residual	 native	 cofactor	 performing	 the	
catalysis.	 Therefore,	 the	 authors	 proposed	 that	 the	 pyridinium	 ring	 substituents	
played	a	role	in	the	binding	to	the	NAD+-binding	pocket	of	HLADH,	and	in	positioning	





substituted	 nicotinamide	 ring	 could	 act	 as	 an	 anchor,	 for	 the	 attachment	 and	
introduction	 of	 metal	 complexes	 within	 TADH.	 TADH	 and	 HLADH	 have	 a	 similar	
cofactor-binding	pocket,	 and	 it	was	 therefore	hypothesised	 that	 similar	 affinity	 for	
NAD+	mimics	would	be	observed.	The	1-benzylnicotinamide	analogue	was	selected,	as	
it	was	 simple	enough	 to	be	 synthesised.	To	 select	a	position	 for	 the	connection	of	



























Figure	4.32.	Design	of	metal	 complexes	connected	 to	nicotinamide	mimics,	 for	 incorporation	 into	
TADH.	The	benzylnicotinamide	anchor	is	represented	in	red.	
The	choice	of	the	metal	catalyst	was	based	on	reported	 literature	results	 for	 imine	
reduction	 by	 transfer	 hydrogenation.182,183	 The	 majority	 of	 reported	 catalysts	














best	 conversions	were	 generally	 obtained	with	 iridium	catalysts.184	 Concerning	 the	
ligand,	 small	N-heterocyclic	 carbenes	 (NHCs)	were	 selected,	 to	minimise	 the	 space	
occupied	by	 the	metal	 complex	 inside	 the	protein.	From	a	 synthetic	point	of	view,	
NHCs	can	be	directly	connected	to	the	nicotinamide	ring,	without	the	need	of	a	linker	
(see	 later),	 thus	 enhancing	 the	 possibility	 to	 position	 the	 metal	 catalyst	 in	 close	
proximity	 to	 the	 nicotinamide	 ring,	 and	 thus	 to	 the	 substrate-binding	 pocket.	
Additionally,	NHC	ligands	have	the	advantage	of	high	thermal	stability,	and	the	ability	
to	tune	the	electronic	properties	of	the	metal	complex.185	Rh(III),	Ir(I	or	III)-	and	Ru(II)-	
N-heterocyclic	 carbenes	 were	 previously	 demonstrated	 to	 perform	 transfer	





Additionally,	 the	 synthesis	and	characterisation	of	a	Rh(I)-NHC	complex	 linked	 to	a	
nicotinamide	 derivative	 was	 recently	 reported	 (12,	 Figure	 4.34).	 The	 report	 also	
demonstrated	 the	 ability	 of	 such	 complexes	 to	 act	 as	 hydride	 ion	 carriers,	 by	




























































Despite	 published	 work	 suggesting	 easier	 handling	 of	 the	 tertiary,	 diisopropyl-
substituted	 nicotinamide,	 this	 substitution	was	 reasoned	 to	 add	 steric	 bulk	 to	 the	
nicotinamide	 anchor,	 and	 the	 primary	 amide	 was	 used	 instead.	Moreover,	 at	 the	
difference	 from	 the	 previously	 published	 methyl-substituted	 Rh-NHC	 11,	 a	 benzyl	
group	was	thought	necessary	for	the	recognition	of	the	substituted	nicotinamide	by	
ADH.	Since	the	selective	N-alkylation	of	the	nicotinamide	vs.	the	imidazole	ring	was	
deemed	difficult,	 benzyl	was	 used	 both	 as	 the	 pyridinium	 functionality	 and	 as	 the	
second	 substituent	of	 the	NHC,	despite	 its	 increased	bulk.	 Functionalisation	of	 the	
nicotinamide	with	 a	metal-NHC	 complex	 at	 the	4-position	has	not	been	previously	
reported	 and	 was	 therefore	 investigated.	 The	 synthesis	 of	 these	 structures	 was	
studied	in	the	following	section.	













































Ullmann	 coupling	 is	 a	 cross-coupling	 reaction	 between	 aryl	 halides	 a	 nucleophile,	
leading	 to	 C-C,	 C-N	 and	 C-O	 bond	 formation.191-196	 It	 is	 essentially	 an	 aromatic	
nucleophilic	 substitution,	 mediated	 by	 Cu(I).	 The	 generally	 accepted	 mechanism	
involves	 Cu(I)	 undergoing	 oxidative	 addition,	 followed	 by	 co-ordination	 to	 the	
nucleophile	and	reductive	elimination	(Figure	4.37,	route	A).	Mechanisms	proposed	
up	until	the	end	of	the	last	century	largely	suggested	the	nucleophile	to	co-ordinate	
first	 (Figure	 4.37,	 route	 B),	 increasing	 the	 electrophilicity	 on	 the	 aromatic	 and	
subsequently	the	susceptibility	to	oxidative	addition.	From	a	recent	review	on	copper-
catalysed	Ullmann	chemistry,	 it	 is	apparent	that	 the	mechanism	depends	upon	the	
specific	substrates	and	reaction	conditions	employed.195		
In	the	reported	synthesis	of	12,	the	use	of	a	“protected”	tertiary	nicotinamide	avoided	
the	 amide	 group	 acting	 as	 a	 nucleophile	 during	 the	 coupling.197,198	Moreover,	 the	

























Initially,	 the	 tertiary	 amide	 16a	 was	 synthesised	 according	 to	 Marsais	 from	
commercially	available	5-bromonicotinic	acid	15a,	in	79	%	yield	after	purification	by	





























and	 4-(1H-imidazol-1-yl)-N,N-diisopropylnicotinamide	 17b	 were	 synthesised	
successfully	 in	 40	 %	 and	 68	 %	 yield,	 respectively.	 The	 yield	 for	 the	 5-imidazolyl	
compound	 17a	 was	 as	 expected	 when	 compared	 to	 the	 literature	 (70%).158	 	 The	
synthesis	 of	 the	 4-imidazolyl	 product	 17b	 demonstrated	 that	 imidazole	 could	
successfully	be	introduced	at	the	4-position	of	the	diisopropylnicotinamide.	However,	
the	lower	yield	suggested	that	coupling	at	the	4-position	was	challenging.		




























110-120 oC, 24 h
Br






















5-(1H-Imidazol-1-yl)nicotinamide	 20a	 was	 successfully	 synthesised	 using	 Colbran’s	























110-120 oC, 24 h
Br
in ACN, 40 oC, 24 h




















110-120 oC, 24 h
Br
in ACN, 40oC, 24 h





























observed	 by	 1H	 NMR;	 however,	 purification	 by	 silica	 gel	 chromatography	 proved	
difficult	and	the	desired	product	could	not	be	isolated.		


















to	 compare	 the	 outcome	 with	 the	 5-bromonicotinamide	 use	 presented	 above.	
However,	 4-bromonicotinamide	 was	 not	 commercially	 available	 and	 attempts	 to	










are	 known	 to	 be	 less	 reactive	 substrates	 than	 aryl	 bromides	 in	 Ullman	 coupling	
reactions.	 However,	 oxidative	 addition	 of	 the	 “protected”	 4-chloronicotinamide	
derivative	 17b	 to	 Cu(I)	 and	 further	 coupling	 to	 imidazole	 was	 successfully	
demonstrated	 in	 the	 previous	 section.	 It	 was	 unlikely	 that	 the	 tertiary	 amide	
substitution	 had	 such	 a	 dramatic	 effect	 on	 the	 reactivity	 of	 the	 aryl	 halide	 during	
oxidative	addition.		
Considering	these	results,	it	was	hypothesised	that	the	presence	of	the	primary	amide	
was	 not	 compatible	 with	 performing	 the	 Ullmann	 coupling	 at	 position	 4	 of	 the	
nicotinamide.	The	primary	amide	from	a	second	nicotinamide	molecule	could	act	as	a	
nucleophile	at	the	place	of	 imidazole;	however,	this	was	not	observed	in	the	crude	
NMR.	 On	 the	 other	 hand,	 intramolecular	 coordination	 of	 the	 amide	 group	 to	 the	































the	 silver	 carbenoid	 (Ag(I)-NHC)	 by	 reaction	 with	 silver	 oxide,	 followed	 by	
transmetalation	 with	 the	 desired	 metal	 complex	 to	 achieve	 the	 final	 metal-NHC	
compound	 (Figure	4.42).202	Advantages	of	 this	method	are	 the	selective	binding	of	
Ag(I)	 to	 the	 -N-CH-N-	 carbon	 of	 the	 imidazolium	 salt,	 the	 lack	 of	 additional	 base	










to	 reproduce	 the	 result	 previously	 reported	 by	 Colbran	 and	 co-workers	 for	 the	
synthesis	 of	 nicotinamide-NHC-metal	 complexes.	 The	 method	 used	 is	 outlined	 in	
Figure	4.42,	with	dichloromethane	as	the	solvent.	No	reaction	was	observed	when	the	






















































Entry	 Basea	 Metal	complex	 Solvent	 Outcome	
1	 Ag2O	 [IrCp*Cl2]2	 MeOH	 No	reaction	





4	 Ag2O	 [Ir(COD)Cl]2	 MeOH	 No	reaction	





7	 Ag2O	 [Ir(COD)Cl]2	 CH2Cl2	(in	situ)b	 No	reaction	
8	 NaOAc	 [IrCp*Cl2]2	 MeOH	 Product	present	
9	 tBuOAc	 [IrCp*Cl2]2	 MeOH	 Product	present	
10	 NaOAc	 [Ir(COD)Cl]2	 MeOH	 No	reaction	
11	 tBuOAc	 [Ir(COD)Cl]2	 MeOH	 No	reaction	
a	Reaction	conditions	when	Ag2O	was	used:	Ag2O	(0.5	eqv.),	ligand	21a	(1.0	eqv.),	metal	complex	(0.5	
eqv.);	 when	 base	 was	 used:	 NaOAc/NaOtBu	 (1.0	 eqv.),	 KCl	 (6.7	 eqv.),	 ligand	 21a	 (1.0	 eqv.),	 metal	
complex	 (0.5	 eqv.):	All	 solvents	were	degassed.	 Entries	 1-6:	 Ligand	21a	 and	Ag2O	added	 to	desired	









metal	 precursors	 in	 the	 reaction	 solvents	 could	 explain	 this.	 Previous	 literature	





On	 the	 other	 hand,	 the	 use	 of	 either	 NaOAc	 or	 NatOBu	 for	 deprotonation	 were	
successful	for	metalation	with	IrCp*,	with	the	presence	of	an	identical	Ir(III)Cp*-ligand	
complex	 obtained	 in	 both	 cases,	 confirmed	 by	 NMR	 and	 mass	 spectrometry.	 No	
metalation	was	 observed	with	 the	 [Ir(COD)Cl]2	precursor,	 probably	 due	 to	 its	 poor	







146.4	 ppm	 in	 the	 imidazolium	 ligand,	 towards	 165-170	 ppm	 in	 the	 Ir-complex.	
However,	 the	presence	of	 two	13C	signals	 in	 the	 Ir-C	 region	 (167.6	and	170.7	ppm)	
suggested	the	 formation	of	a	second	C-Ir	bond.	Cyclometallation	by	 intramolecular						
C-H	activation	has	previously	been	reported	for	NHC	complexes	in	the	presence	of	a	
tBuO-	 base.	 Four	 aromatic	 C-H	 positions	were	 available	 for	 cyclometalation	 in	 the	
complexation	of	Ir(Cp*)	with	21a:	two	of	these	are	on	the	nicotinamide	ring,	whilst	
the	other	two	on	the	N-benzyl	functionality	of	the	NHC	(Figure	4.43).	
Careful	 inspection	 of	 the	 NMR	 data	 suggested	 that	 C-H	 insertion	 occurred	 at	 the	











It	 was	 difficult	 to	 assert	 unambiguously,	 from	 this	 NMR	 structure,	 whether	 the	
insertion	occurred	at	position	2	or	6	of	the	pyridinium	ring.	However,	the	13C	signal	at	
position	 6	 seems	 to	 be	 the	 same	when	 comparing	 the	 ligand	 and	 the	 Ir-complex,	







In	 conclusion,	 an	 NHC	 carbene	 precursor	 was	 introduced	 at	 the	 5-position	 of	
benzylnicotinamide,	to	yield	21a	in	reasonable	yields.	Substitution	at	the	4-position	of	
benzylnicotinamide	proved	difficult	under	the	conditions	tested.	On	the	other	hand,	
metalation	 of	 the	 5-substituted	 ligand	21a	 resulted	 in	 a	 new	 Ir-NHC	 complex	24a,	
which	underwent	cyclometalation	at	position	6,	it	is	thought.	Whilst	this	structure	was	





Preliminary	 investigations	 into	 the	 ability	 of	 24a	 to	 catalyse	 ketone	 and	 imine	
reduction	were	performed	under	both	organic	and	aqueous	transfer	hydrogenation	
conditions.	Isopropanol	was	employed	as	the	solvent	and	source	of	hydrogen	in	the	
organic	 reaction,	 while	 a	 buffer	 solution	 containing	 sodium	 formate	 provide	 the	
hydride	in	aqueous	reactions.	Model	ketone	and	imine	substrates	were	acetophenone	






























organic conditions: [H] = iPrOH / NatOBu; solvent = iPrOH







were	 observed	 by	 1H	 NMR.	 When	 the	 substrates	 and	 reagents	 were	 diluted,	 to	
increase	compatibility	with	enzyme	presence	in	subsequent	experiments,	conversion	
decreased	 to	 21	 %	 (Table	 4.28,	 entry	 2).	 Transfer	 hydrogenation	 of	 3,4-
dihydroisoquinoline	2	at	low	concentration	yielded	a	similar	conversion	of	24	%	(Table	
4.28,	 entry	 3).	 On	 the	 other	 hand,	 no	 reaction	 was	 observed	 when	 2-methyl-1-
pyrroline	1	was	used.	These	results	demonstrated	that	the	new	Ir-NHC	complex	was	
active	for	transfer	hydrogenation	reactions	to	ketones	and	imines.	No	attempts	were	




Entry	 Substrate	 Substrate	concentration	 Conversion	(%)
a	
1	 acetophenone	 3	M	 76b	
2	 acetophenone	 0.3	M	 21	
3	 3,4-dihydroisoquinoline	 0.3	M	 24	
4	 2-methyl-1-pyrroline	 0.3	M	 0	
The	reaction	was	performed	at	reflux,	under	N2	for	24	h	containing	substrate	(0.15	mmol,	300	mM),	10	
mol	%	NaOtBu	(0.015	mmol),	1	mol	%	 Ir	complex	24a	 (0.3	mM,	final	conc.)	 in	 iPrOH	(0.5	mL).	After	
completion	 solvent	 removed	 and	 products	 sent	 for	 NMR	 analysis.	 a	 Conversions	 calculated	 as	 a	




Following	 from	 the	 encouraging	 results	 observed	 for	 hydrogen	 transfer	 in	 organic	
conditions,	 complex	 24a	 was	 investigated	 as	 a	 catalyst	 for	 the	 same	 reactions	 in	
aqueous	 conditions.	 To	 enhance	 solubility	 of	 both	 24a	 and	 the	 substrates	 in	 the	
aqueous	 reaction	 solvent,	 stock	 solutions	 were	 prepared	 in	 DMF,	 at	 a	 final	
167	
	
concentration	 of	 the	 organic	 solvent	 in	 the	 reaction	 of	 4-7	%	 (v	 /	 v).	 Under	 these	
conditions,	 reduction	of	ketone	to	the	corresponding	alcohol	occurred	with	a	19	%	









1	 acetophenone	 4	%	DMF	 19	
2	 3,4-dihydroisoquinoline	 7	%	DMF	 100	
3	 2-methyl-1-pyrroline	 4	%	DMF	 0	
4	 acetophenone	 4	%	ACN	 0	
5	 3,4-dihydroisoquinoline	 5	%	ACN	 100	





















obtained	with	 the	 imine	was	most	 encouraging,	 as	 for	 the	 purposes	 of	 this	 study,	
catalyst	24a	was	required	to	react	efficiently	in	mild	conditions	in	order	to	be	used	in	
conjunction	with	TADH.	
4.4.4.3	Transfer	hydrogenation	of	 ketones	and	 imines	using	24a	 in	 the	presence	of	
TADH	
Next,	 investigations	 into	 hydrogen	 transfer	 reactions	 catalysed	 by	 24a	 were	
performed	in	the	presence	of	TADH	(Table	4.30).		Reactions	were	performed	with	the	








Entry	 Substrate	 Organic	solvent	(%	v	/	v)	 Conversion	(%)a	
1	 acetophenone		 4	%	ACN	 0	
2	 3,4-dihydroisoquinoline	 5	%	ACN	 100	
3	 3,4-dihydroisoquinoline	 5	%	ACN	 100b	
4	 2-methyl-1-pyrroline	 4	%	ACN	 0	
5	 2-methyl-1-pyrroline	 4	%	ACN	 0b	











even	 at	 low	 substrate	 concentrations	 catalyst.	 However,	 the	 5-membered	 ring	
aliphatic	imine,	2-methyl-1-pyrroline	1	was	not	converted.	The	catalyst	was	shown	to	
perform	 effectively	 in	 the	 presence	 of	 TADH,	 however	 the	 performance	 was	
unaffected	in	the	presence	of	NADH,	suggesting	no	affinity	for	the	co-factor	binding	
pocket.		
To	 investigate	 the	 affinity	 of	 the	 iridium	 complex	 for	 TADH,	 kinetic	 studies	 were	
performed,	where	the	inhibition	of	TADH	activity	was	determined	with	both	the	Ir-
complex	24a	and	the	corresponding	ligand	21a.		
4.4.5	 Inhibition	 studies	of	 TADH	by	nicotinamide-functionalised	 ligand	and	metal	
complex	
Preliminary	 studies	 were	 performed,	 where	 Michaelis-Menten	 kinetics	 were	
determined	 with	 varying	 cofactor	 concentrations	 in	 the	 presence	 of	 the	 metal	
complex	24a	or	of	the	ligand	21a,	in	order	to	assess	whether	inhibition	occurs.	Binding	
of	 the	 modified	 nicotinamide	 mimics	 to	 the	 cofactor-binding	 site	 would	 lead	 to	
reversible	competitive	inhibition	that	would	increase	KM,	thus	lowering	the	affinity	for	
the	 cofactor,	 but	 would	 not	 affect	 Vmax.	 Investigations	 were	 performed	 in	 the	
reduction	direction	with	cyclohexanone	(500	mM)	and	NADH	(0.5-12.5	mM)	as	the	
substrates,	 and	 with	 21a	 or	 24a	 (0.05-0.25	mM)	 as	 inhibitors.	 A	 control	 was	 also	















Figure	 4.46.	 Lineweaver-Burk	 plot	 illustrating	 the	 inhibitory	 effect	 of	 nicotinamide-functionalised	
ligand	21a	in	the	reductive	direction	using	NADH	and	cyclohexanone	as	substrates.	Specific	activities	
were	determined	 in	 the	 reductive	direction	at	60	 oC,	using	TADH	(5.6	µg),	NADH	(0.01,	0.025,	0.05,	
0.075,	0.1,	0.25	mM)	as	substrate,	cyclohexanone	(20	mM)	as	secondary	substrate,	in	50	mM	Bis-Tris	
buffer	 pH	 6.0	 containing	 2	 %	 v/v	 DMF	with	 nicotinamide-functionalised	 ligand,	 21a	 as	 inhibitor	 at	
concentration:	(l)	0	mM	,	()	0.1	mM,	(¾)	0.25	mM.	
The	 data	 from	 Table	 4.31	 showed	 irregular	 trends	 for	 these	 inhibition	 studies,	
although	 relatively	 low	 errors	were	 obtained	 from	 triplicate	 experiments,	 showing	
that	 the	 results	 were	 reproducible.	 The	 typical	 trends	 expected	 for	 competitive	
inhibition	were	not	observed.	From	the	KM	and	Vmax	calculated	values	(Table	4.31),	it	
appeared	 that	 Vmax	 remained	 relatively	 unchanged	 irrespective	 of	 the	 inhibitor	
concentration,	 while	 KM	 was	 observed	 to	 increase	 as	 the	 ligand	 concentration	







































The	 same	 inhibition	 experiments	 performed	with	 the	 ligand	were	 repeated	 in	 the	
presence	of	the	Ir-NHC	complex	24a.	Inhibition	was	observed	at	lower	concentrations	
of	 the	 Ir-NHC	 complex,	 and	 experiments	 were	 performed	 at	 the	 lower	 inhibitor	
concentrations	 of	 0.1	mM	 and	 0.05	mM.	 The	 solubility	 of	 24a	 in	 acetonitrile	 was	
higher,	 allowing	 the	use	of	 this	 solvent	 in	 the	 reaction	mixture	 at	 5	%	 (v	 /	 v).	 The	
kinetics	 results	 were	 used	 to	 produce	 a	 Lineweaver-Burk	 plot	 (Figure	 4.47),	 and	
Michaelis-Menten	 plot	 (Appendix	 8),	 from	 which	 the	 KM	 and	 Vmax	 values	 were	
calculated	and	compared	(Table	4.32).	
In	comparison	to	the	results	obtained	with	ligand	21a,	inhibition	studies	with	the	Ir-
NHC	 complex	 24a	 showed	 clear	 and	 reproducible	 trends	 corresponding	 to	 mixed	
inhibition.	 The	 KM	 was	 observed	 to	 increase,	 whereas	 the	 Vmax	 decreased	 with	
increasing	 concentration	 of	 Ir-NHC.	 This	 type	 of	 inhibition	 suggests	 binding	 of	 the	
inhibitor	at	a	different	site	from	the	cofactor	binding	site.	
The	 increased	KM	suggested	that	 the	 Ir	complex	 inhibited	the	binding	of	 the	NADH	
cofactor,	 because	 more	 NADH	 was	 required	 to	 reach	 half	 Vmax.	 However,	 the	
decreased	Vmax	suggested	that	NADH	could	not	outcompete	the	inhibitor	binding	at	
high	concentrations.	In	contrast	to	competitive	binding,	where	the	inhibitor	occupies	







Figure	4.47.	 Lineweaver-Burk	 illustrating	 the	 inhibitory	effect	of	 Ir	 complex	 (24a)	 in	 the	 reductive	




This	 study	 showed	 that	 both	 the	 ligand	 and	 Ir	 catalyst	 interacted	 with	 TADH	 to	







































Two	 nicotinamide-functionalised	 N-heterocyclic	 ligand	 scaffolds	 were	 designed	 as	




Synthesis	 of	 the	 5-imidazoyl-functionalised	 benzylated	 nicotinamide	 ring	 was	
successfully	 achieved,	 and	 the	 resulting	 [(Cp*)Ir(NHC)]	 complex	 was	 formed.	
Cyclometalation	was	observed	at	position	6	of	the	nicotinamide	ring,	and	the	resulting	
Ir-complex	structure	was	elucidated	by	NMR	and	MS	studies.	On	the	other	hand,	the	






dihydroisoquinoline).	 Similar	 conversions	 (~20	 %)	 were	 obtained	 for	 the	 two	
substrates	in	organic	solvent,	using	isopropanol	as	hydride	donor.	On	the	other	hand,	
the	activity	 towards	 the	 imine	substrate	was	much	higher	 in	aqueous	buffer,	using	
sodium	formate.		
Inhibition	 studies	 showed	 that	 the	 Ir-catalyst	 interfered	with	 the	 enzyme	 kinetics,	
acting	 as	 a	mixed	 inhibitor	 for	 the	 enzyme	when	NADH	 concentration	was	 varied.	
Whilst	 the	 catalyst	 remained	 active	 in	 the	 presence	 of	 TADH,	 no	 decrease	 in	








active	 site	 of	 a	 thermostable	 alcohol	 dehydrogenase,	 to	 introduce	 reaction	
promiscuity	towards	imine	reduction.	The	results	obtained	allowed	an	increase	in	the	
understanding	of	how	imines	interact	with	the	active	site	of	alcohol	dehydrogenases.	
Variants	 of	 TADH	 containing	 protic	 residues	 in	 the	 active	 site	 were	 successfully	
designed.	 Rh-containing	 TADH	 variants	 were	 also	 prepared,	 however	 the	 precise	
localisation	of	 the	Rh	 at	 the	place	of	 the	 catalytic	 zinc	was	not	 determined.	 Imine	
reduction	 activity	 was	 not	 identified	 in	 any	 of	 the	 modified	 enzymes,	 under	 the	
conditions	employed.	In	a	different	approach,	a	novel	iridium(III)	complex	bearing	a	
nicotinamide	 anchor	was	 designed	 for	 introduction	 into	 TADH,	 and	 showed	 imine	







were	 observed	 with	 reproducing	 the	 TADH	 preparation	 as	 characterised	 in	 the	
literature.	 Expression	of	 TADH	was	 successfully	 achieved	 in	E.	 coli,	after	 growth	at							
30	oC	and	induction	with	0.4	mM	IPTG	at	30	oC.	A	heat	purification	step	was	applied	at	
80	oC	for	20	min,	yielding	relatively	pure	protein,	as	estimated	by	SDS-PAGE.	The	zinc	
content	 of	 this	 protein	 was	 observed	 to	 be	 lower	 than	 expected	 by	 ICP-MS.	 Size	





ring	 2-methyl-1-pyrroline	 1	 and	 6-membered	 ring	 3,4-dihydroisoquinoline	 2,	 was	










imine	 1	 and	 reduced	 amine	 3	 showed	 mixed	 inhibition	 for	 these	 compounds,	
suggesting	 that	 inhibitor	 and	 substrate-binding	 sites	 were	 different.	 For	 example,	
imines	might	bind	at	the	place	of	NADH,	and	/	or	at	another	position	within	the	active	
site.	 The	 amine	 compound	 was	 shown	 to	 have	 inhibitory	 effect	 at	 lower	
concentrations	compared	to	the	imine,	thus	suggesting	a	possible	interaction	with	the	
catalytic	zinc.		
Furthermore,	 docking	 studies	 of	 imines	 1	 and	 3	 inside	 cofactor-bound	 TADH	
confirmed	 the	 possibility	 of	 their	 acceptance	 in	 the	 active	 site.	 Their	 preferred	
orientation	was	similar	to	that	of	a	docked	model	ketone,	within	range	for	both	proton	





NADH	 as	 substrate	 should	 also	 be	 performed,	 to	 assess	 whether	 imines	 act	 as	




imine	 reductase	 active	 site.	 While	 the	 mutants	 were	 successfully	 expressed	 and	
purified,	 no	 imine	 reduction	 was	 observed.	 It	 was	 thought	 that	 site-directed	
mutagenesis	was	not	suited	for	introduction	of	imine	activation,	because	it	could	not	
reconstitute	 the	 interplay	 between	 parameters	 that	 can	 affect	 reactivity,	 such	 as	




















the	 instability	 of	 the	 protein	 in	 the	 absence	 of	 zinc.	 Encouragingly,	 activity,	 zinc	
content	 and	 protein	 concentration	 all	 increased	 upon	 zinc	 reinsertion	 by	 dialysis	
against	 a	 buffer	 solution	 containing	 zinc	 acetate	 (20	µM)	 at	 pH	 6.5	 and	 4	 oC.	 This	
suggested	that	most	of	the	zinc	removed,	and	thus	reinserted,	was	from	the	catalytic	





















would	 present	 the	metal	 complex	 towards	 the	 substrate-binding	 pocket	 in	 TADH.	
Synthesis	 of	 the	 5-imidazoyl-functionalised	 benzylated	 nicotinamide	 ring	 was	
successfully	achieved,	whereas	the	functionalisation	at	position	4	of	the	nicotinamide	
ring	with	a	NHC	precursor	was	unsuccessful	as	a	result	of	the	inefficiency	of	Ullmann	
coupling	 at	 this	 position.	 This	 was	 suggested	 to	 be	 a	 result	 of	 intramolecular	
coordination	of	the	primary	nicotinamide	to	the	Cu	catalyst.	Future	investigations	into	
Ullmann	 coupling	 at	 this	 position	 could	 focus	 on	 using	 an	 amide	 protecting	 group	
during	 the	coupling,	which	would	complicate	 the	synthesis,	but	might	 improve	 the	
coupling	results.	
Complexation	 of	 the	 [Cp*Ir(III)Cl2]2	 precursor	 to	 the	 5-imidazoyl-functionalised	
benzylated	 nicotinamide	 ring	 was	 successfully	 achieved,	 however	 low	 yields	 were	












confirm	 this	 lack	of	 interaction.	 In	particular,	 the	enantioselectivity	of	 the	 reaction	
should	be	determined,	in	order	to	assess	whether	TADH	has	any	effect	on	the	catalysis.	
Additionally,	 the	 interaction	 of	 the	 Ir-NHC	 catalyst	 with	 NADH	 should	 also	 be	
investigated.	Hydride	 transfer	 from	NADH	 to	 an	 Ir(III)	 cyclometalated	 complex	 has	
previously	been	reported,	and	might	be	responsible	for	the	inhibition	results	obtained	
with	the	Ir-complex.		
The	 affinity	 of	 benzyl	 nicotinamide	mimics	 is	 currently	 a	 subject	 of	 debate	 in	 the	
scientific	community,	with	two	research	groups	reporting	contradicting	results	with	
respect	 to	 their	 activity	 towards	 ADHs.	 Affinity	 studies	 should	 be	 performed	with	
benzyl	nicotinamide	and	TADH,	to	ascertain	the	 interaction	of	 this	anchor	with	the	
enzyme.	 The	 use	 of	 other	 pyridinium	 substituents,	 such	 as	 ribose,	 might	 prove	
beneficial	to	increase	this	affinity.	The	group	of	Hollmann	reported	micromolar	affinity	
of	 substituted	 nicotinamide	 for	 enoate	 reductases,	 and	 these	 could	 constitute	 an	
alternative	starting	point	to	engineer	imine	reduction	promiscuity	inside	a	reductase	
with	a	different	functionality.	
In	 conclusion,	 this	 thesis	 provided	 an	 insight	 into	 the	 chemical	 and	 genetic	
modification	of	TADH	for	promiscuity	 towards	 imines.	Continued	efforts	 in	enzyme	
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1H-NMR	 Transfer	 hydrogenation	 reaction	 with	 24a	 showing	 conversion	 of	
acetophenone	to	1-phenylethanol	
	
1H-NMR	 Transfer	 hydrogenation	 reaction	 with	 24a	 showing	 conversion	 of	 3,4-
dihydroquinoline	to	1,2,3,4-tetrahydroisoquinoline	
	
